US20090287303A1 - Physiologically harmonized tricuspid annuloplasty ring - Google Patents

Physiologically harmonized tricuspid annuloplasty ring Download PDF

Info

Publication number
US20090287303A1
US20090287303A1 US12/120,184 US12018408A US2009287303A1 US 20090287303 A1 US20090287303 A1 US 20090287303A1 US 12018408 A US12018408 A US 12018408A US 2009287303 A1 US2009287303 A1 US 2009287303A1
Authority
US
United States
Prior art keywords
segment
ring
free end
ring body
septal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/120,184
Inventor
Alain Carpentier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences Corp
Original Assignee
Edwards Lifesciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edwards Lifesciences Corp filed Critical Edwards Lifesciences Corp
Priority to US12/120,184 priority Critical patent/US20090287303A1/en
Priority to PCT/US2008/063758 priority patent/WO2009139776A1/en
Priority to CN200880129174.0A priority patent/CN102088930B/en
Priority to EP08755581.9A priority patent/EP2306933B1/en
Priority to CA2721143A priority patent/CA2721143C/en
Priority to JP2011509457A priority patent/JP5390598B2/en
Assigned to EDWARDS LIFESCIENCES CORPORATION reassignment EDWARDS LIFESCIENCES CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CARPENTIER, ALAIN
Publication of US20090287303A1 publication Critical patent/US20090287303A1/en
Priority to US13/600,040 priority patent/US9937041B2/en
Priority to US15/941,499 priority patent/US20180221150A1/en
Priority to US17/459,211 priority patent/US11903830B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2445Annuloplasty rings in direct contact with the valve annulus
    • A61F2/2448D-shaped rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2445Annuloplasty rings in direct contact with the valve annulus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0018Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0019Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in hardness, e.g. Vickers, Shore, Brinell

Definitions

  • the present invention relates generally to medical devices and particularly to a tricuspid annuloplasty ring.
  • the heart is a hollow muscular organ having four pumping chambers: the left and right atria and the left and right ventricles, each provided with its own one-way valve.
  • the natural heart valves are identified as the aortic, mitral (or bicuspid), tricuspid and pulmonary, and are each mounted in an annulus comprising dense fibrous rings attached either directly or indirectly to the atrial and ventricular muscle fibers. Each annulus defines a flow orifice.
  • Heart valve disease is a widespread condition in which one or more of the valves of the heart fails to function properly.
  • Diseased heart valves may be categorized as either stenotic, wherein the valve does not open sufficiently to allow adequate forward flow of blood through the valve, and/or incompetent, wherein the valve does not close completely, causing excessive backward flow of blood through the valve when the valve is closed.
  • Valve disease can be severely debilitating and even fatal if left untreated.
  • Various surgical techniques may be used to repair a diseased or damaged valve.
  • the damaged leaflets are excised and the annulus sculpted to receive a replacement valve.
  • Another less drastic method for treating defective valves is through repair or reconstruction, which is typically used on minimally calcified valves.
  • the most widely used repair technique is remodeling annuloplasty first proposed by the same inventor in which the deformed valve annulus is reshaped by attaching a prosthetic annuloplasty repair segment or ring to the valve annulus.
  • the annuloplasty ring is designed to support the functional changes that occur during the cardiac cycle: maintaining coaptation and valve integrity to prevent reverse flow while permitting good hemodynamics during forward flow.
  • the present invention relates generally to medical devices and particularly to a tricuspid annuloplasty ring.
  • the heart is a hollow muscular organ having four pumping chambers: the left and right atria and the left and right ventricles, each provided with its own one-way valve.
  • the natural heart valves are identified as the aortic, mitral (or bicuspid), tricuspid and pulmonary, and are each mounted in an annulus comprising dense fibrous rings attached either directly or indirectly to the atrial and ventricular muscle fibers. Each annulus defines a flow orifice.
  • Heart valve disease is a widespread condition in which one or more of the valves of the heart fails to function properly.
  • Diseased heart valves may be categorized as either stenotic, wherein the valve does not open sufficiently to allow adequate forward flow of blood through the valve, and/or incompetent, wherein the valve does not close completely, causing excessive backward flow of blood through the valve when the valve is closed.
  • Valve disease can be severely debilitating and even fatal if left untreated.
  • Various surgical techniques may be used to repair a diseased or damaged valve.
  • the damaged leaflets are excised and the annulus sculpted to receive a replacement valve.
  • Another less drastic method for treating defective valves is through repair or reconstruction, which is typically used on minimally calcified valves.
  • the most widely used repair technique is remodeling annuloplasty first proposed by the same inventor in which the deformed valve annulus is reshaped by attaching a prosthetic annuloplasty repair segment or ring to the valve annulus.
  • the annuloplasty ring is designed to support the functional changes that occur during the cardiac cycle: maintaining coaptation and valve integrity to prevent reverse flow while permitting good hemodynamics during forward flow.
  • the annuloplasty ring typically comprises an inner substrate of a metal such as rods or bands of stainless steel or titanium, or a flexible material such as silicone rubber or Dacron cordage, covered with a biocompatible fabric or cloth to allow the ring to be sutured to the fibrous annulus tissue.
  • Annuloplasty rings may be stiff or flexible, split or continuous, and may have a variety of shapes, including circular, U-shaped, C-shaped, or kidney-shaped. Examples are seen in U.S. Pat. Nos. 5,041,130, 5,104,407, 5,201,880, 5,258,021, 5,607,471 and, 6,187,040 B1.
  • annuloplasty rings Whether totally flexible, rigid, or semi-rigid, annuloplasty rings have sometimes been associated with a certain degree of arrhythmia or a 10% to 15% incidence at 10 years of ring dehiscence and/or conduction tissue disturbance.
  • the present invention is intended to reduce the complications.
  • FIG. 1 is a schematic representation of the AV junctions within the heart and the body in the left anterior oblique projection.
  • the body is viewed in the upright position and has 3 orthogonal axes: superior-inferior, posterior-anterior, and right-left.
  • Traditional nomenclature for the AV junctions derives from a surgically distorted view, placing the valvular rings in a single horizontal plane with antero-posterior and right-left lateral coordinates.
  • the descriptive terms used, however, are anatomically inaccurate.
  • An accurate account of the coordinates of the valvular orifices is provided by the simple expedient of relating appropriately the view obtained in left anterior oblique projection to the supero-inferior and antero-posterior coordinates of the body.
  • FIG. 2 is a cutaway view of the heart from the front, or anterior, perspective, with most of the primary structures marked.
  • the pathway of blood in the heart is from the right atrium to the right ventricle through the tricuspid valve, to and from the lungs, and from the left atrium to the left ventricle through the mitral valve.
  • the present application has particular relevance to the repair of the tricuspid valve, which regulates blood flow between the right atrium and right ventricle, although certain aspects may apply to repair of other of the heart valves.
  • the tricuspid and mitral valves together define the atrioventricular (AV) junctions.
  • AV atrioventricular
  • SA node sinoatrial node
  • AV node atrioventricular node
  • Purkinje fibers On the rear wall of the right atrium is a barely visible knot of tissue known as the sinoatrial, or SA node. This tiny area is the control of the heart's pacemaker mechanism.
  • Impulse conduction normally starts in the SA node. It generates a brief electrical impulse of low intensity approximately 72 times every minute in a resting adult.
  • the impulses reach the AV node they are relayed by way of the several bundles of His and Purkinje fibers to the ventricles, causing them to contract.
  • the integrity and proper functioning of the conductive system of the heart is critical for good health.
  • FIG. 3 is a schematic view of the tricuspid valve orifice seen from its inflow side (from the right atrium), with the peripheral landmarks labeled as: antero septal commissure, anterior leaflet, posterior commissure, posterior leaflet, postero septal commissure, and septal leaflet. Contrary to traditional orientation nomenclature, the tricuspid valve is nearly vertical, as reflected by these sector markings. From the same viewpoint, the tricuspid valve 20 is shown surgically exposed in FIG. 4 with an annulus 22 and three leaflets 24 a , 24 b , 24 c extending inward into the flow orifice. Chordae tendineae 26 connect the leaflets to papillary muscles located in the RV to control the movement of the leaflets.
  • the tricuspid annulus 22 is an ovoid-shaped fibrous ring at the base of the valve that is less prominent than the mitral annulus, but larger in circumference.
  • the three leaflets in FIG. 4 are identified as septal 24 a , anterior 24 b , and posterior (or “mural”) 24 c .
  • the leaflets join together over three prominent zones of apposition, and the peripheral intersections of these zones are usually described as commissures 28 .
  • the leaflets 24 are tethered at the commissures 28 by the fan-shaped chordae tendineae 26 arising from prominent papillary muscles originating in the right ventricle.
  • the septal leaflet 24 a is the site of attachment to the fibrous trigone, the fibrous “skeletal” structure within the heart.
  • the anterior leaflet 24 b largest of the 3 leaflets, often has notches.
  • the posterior leaflet 24 c smallest of the 3 leaflets, usually is scalloped.
  • the ostium 30 of the right coronary sinus opens into the right atrium, and the tendon of Todaro 32 extends adjacent thereto.
  • the AV node 34 and the beginning of the bundle of His 36 are located in the supero-septal region of the tricuspid valve circumference.
  • the AV node 34 is situated directly on the right atrial side of the central fibrous body in the muscular portion of the AV septum, just superior and anterior to the ostium 30 of the coronary sinus 30 . Measuring approximately 1.0 mm ⁇ 3.0 mm ⁇ 6.0 mm, the node is flat and oval.
  • the AV node 34 is located at the apex of the triangle of Koch 38 , which is formed by the tricuspid annulus 22 , the ostium 30 of the coronary sinus, and the tendon of Todaro 32 .
  • the AV node 34 continues on to the bundle of His 36 , typically via a course inferior to the commissure 28 between the septal 24 a and anterior 24 b leaflets of the tricuspid valve; however, the precise course of the bundle of His 36 in the vicinity of the tricuspid valve may vary. Moreover, the location of the bundle of His 36 may not be readily apparent from a resected view of the right atrium because it lies beneath the annulus tissue.
  • the triangle of Koch 30 and tendon of Todaro 32 provide anatomic landmarks during tricuspid valve repair procedures.
  • a major factor to consider during surgery is the proximity of the conduction system (AV node 34 and bundle of His 36 ) to the septal leaflet 24 a .
  • AV node 34 and bundle of His 36 the conduction system
  • surgeons must avoid placing sutures too close to or within the AV node 34 .
  • C-shaped rings are good choices for tricuspid valve repairs because they allow surgeons to position the break in the ring adjacent the AV node 34 , thus avoiding the need for suturing at that location.
  • a rigid C-shaped ring of the prior art is the Carpentier-Edwards Classic® Tricuspid Annuloplasty Ring sold by Edwards Lifesciences Corporation of Irvine, Calif., which is seen in FIGS. 5A and 5B .
  • the planar ring 40 has an inner titanium core (not shown) covered by a layer of silicone and fabric. Rings for sizes 26 mm through 36 mm in 2 mm increments have outside diameters (OD) between 31.2-41.2 mm, and inside diameters (ID) between 24.3-34.3 mm. These diameters are taken along the “diametric” line spanning the greatest length across the ring because that is the conventional sizing parameter.
  • a gap G between free ends 42 a , 42 b in each provides the discontinuity to avoid attachment over the AV node 34 .
  • the gap G for the various sizes ranges between about 5-8 mm, or between about 19%-22% of the labeled size.
  • the gap G is sized just larger than the AV node 34 . Despite this clearance, some surgeons are uncomfortable passing sutures so close to the conductive AV node 34 , particularly considering the additional concern of the bundle of His 36 .
  • a flexible C-shaped tricuspid ring is sold under the name SoveringTM by Sorin Biomedica Cardio S.p.A. of Via Crescentino, Italy.
  • the SoveringTM is made with a radiopaque silicone core covered with a knitted polyester (PET) fabric so as to be totally flexible. Rings for sizes 28 mm through 36 mm in 2 mm increments have outside diameters (OD) between 33.8-41.8 mm, and inside diameters (ID) between 27.8-35.8 mm.
  • OD outside diameters
  • ID inside diameters
  • a gap between the free ends provides a discontinuity to avoid attachment over the AV node.
  • the gap for the various sizes ranges between about 18-24 mm, or between about 60%-70% of the labeled size. Although this gap helps avoid passing sutures close to the conductive AV node 34 and bundle of His 36 , the ring is designed to be attached at the commissures on either side of the septal leaflet and thus no support is provided on the septal side.
  • the present invention provides a tricuspid annuloplasty ring including a ring body generally arranged in a plane and about an axis along an inflow-outflow direction, the ring body being discontinuous so as to define a first free end and a second free end separated across a gap, the two free ends being bent out of the plane in an inflow direction.
  • the two free ends are flexible and can be bent to have an axial height of between about 1-4 mm out of the plane.
  • the ring body defines a generally asymmetric ovoid shape and extends in a clockwise direction from a first free end located adjacent the antero-septal commissure when implanted, as seen looking at the inflow side thereof, around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point.
  • the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus.
  • the ring body has an arcuate bulge out of the plane toward the inflow side at the fourth segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus. Still further, the ring body desirably has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end, or comprises at least one hinge point that is locally more flexible than adjacent segments. In one preferred construction, the ring body comprises a plurality of concentric peripheral bands having an axial dimension which is larger adjacent the first free end than adjacent the second free end. In a preferred embodiment, the ring has a long dimension in millimeters, and the free ends are separated by a distance of between about 40%-50% of the long dimension.
  • a prosthetic tricuspid annuloplasty ring having a long dimension in millimeters, comprises an asymmetric generally ovoid ring body.
  • the ring body is generally arranged in a plane and about an axis along an inflow-outflow direction and is discontinuous so as to define two free ends.
  • the ring body has a length and shape such that if a first free end is implanted adjacent an antero septal commissure of the tricuspid annulus, the ring body conforms to the tricuspid annulus and a second end is located adjacent a septal leaflet thereof, and the free ends are separated across a gap having a dimension of between about 40%-50% of the long dimension.
  • the ring body extends in a clockwise direction from the first free end, as seen looking at the inflow side thereof around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point.
  • the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus.
  • the ring body has an arcuate bulge out of the plane toward the inflow side at the fourth segment.
  • the ring body desirably has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end, or comprises at least one hinge point that is locally more flexible than adjacent segments.
  • a prosthetic tricuspid annuloplasty ring comprises an asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction with a first free end located adjacent an antero-septal commissure when implanted and a second free end located at a septal point.
  • the ring body extends in a clockwise direction as seen looking at an inflow side from the first free end around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end.
  • the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment so as to accommodate an anatomical bulge of the aorta into the tricuspid annulus.
  • the ring body may also have an arcuate bulge out of the plane toward the inflow side at the fourth segment.
  • the ring body has a varying flexibility and the fourth segment is relatively more flexible than the third segment.
  • the first free end may also be stiffer than the second free end.
  • the varying flexibility comprises at least one hinge point that is locally more flexible than adjacent segments.
  • asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction with a first free end located adjacent an antero-septal commissure when implanted and a second free end located at a septal point.
  • the ring body extends in a clockwise direction as seen looking at an inflow side from the first free end around a first segment, an second segment, a third segment, and a fourth segment that terminates in the second free end.
  • the ring body has a variable flexibility comprising at least one hinge point that is locally more flexible than adjacent segments. Desirably, the hinge point is located at the approximate midpoint of the ring body. Alternatively, there are two hinge points located approximately diametrically opposite one another so that the ring flexes generally in a plane.
  • FIG. 1 is a schematic representation of the AV junctions within the heart and the body in the left anterior oblique projection
  • FIG. 2 is a cutaway view of the heart from the front, or anterior, perspective
  • FIG. 3 is a schematic plan view of the tricuspid annulus with typical orientation directions noted as seen from the inflow side;
  • FIG. 4 is a plan view of the native tricuspid valve and surrounding anatomy from the inflow side;
  • FIG. 6 is a plan view of the native tricuspid valve and surrounding anatomy from the inflow side with the annuloplasty ring of FIGS. 5A-5B implanted;
  • FIGS. 7A-7C are plan and septal and anterior elevational views, respectively, of an exemplary tricuspid annuloplasty ring of the present invention illustrating its free ends bent toward the inflow side and an antero-superior bulge;
  • FIG. 8 is a plan view of the native tricuspid valve and surrounding anatomy from the inflow side with the annuloplasty ring of FIGS. 7A-7B implanted;
  • FIGS. 9A-9C are plan and septal and anterior elevational views, respectively, of the exemplary tricuspid annuloplasty ring of FIGS. 7A-7B with portions cutaway to show internal details;
  • FIGS. 10A-10D are sectional views taken along respective section lines in FIG. 9A .
  • the present invention provides an improved tricuspid annuloplasty ring that better conforms to the native annulus and is shaped to protect certain features of the surrounding anatomy.
  • the ring of the present invention is designed to support a majority of the tricuspid annulus without risking injury to the leaflet tissue and heart's conductive system, such as the AV node 34 and bundle of His 36 (see FIG. 4 ).
  • the present ring is contoured to better approximate the three-dimensional shape of the tricuspid annulus; specifically, the ring is substantially planar but includes a bulge in the inflow direction at the location of the bulge created by the adjacent aorta. The bulge helps reduce stress between the ring and surrounding tissue, and thus the potential for tearing or ring dehiscence.
  • Another feature that matches the present tricuspid ring with the physiological features of the annulus is a variable flexibility from a relatively stiff first segment to a relatively flexible fourth segment.
  • This varying flexibility permits the ring to adapt (harmonize) its motion and 3-dimensional shape to that of the annulus, rather than impose its own motion and 3-D geometry thereto which tends to increase the risk of ring dehiscence.
  • the motion of the tricuspid annulus during systole-diastole is believed to exert some torsional forces on the implanted ring, and the variable flexibility accommodates such torques.
  • localized points of flexibility or “hinges” around the ring as described herein may best conform and harmonize the physical properties of the ring to the annulus motion, while at the same time providing the needed corrective support.
  • the present tricuspid ring might also be applicable and beneficial to rings for other of the heart's annuluses.
  • the present ring includes upturned or bent free ends that help reduce abrasion on the adjacent leaflets.
  • the same structure might be used in a discontinuous ring for the mitral valve annulus.
  • axis in reference to the illustrated ring, and other non-circular or non-planar rings, refers to a line generally perpendicular to the ring that passes through the area centroid of the ring when viewed in plan view. “Axial” or the direction of the “axis” can also be viewed as being parallel to the direction of blood flow within the valve orifice and thus within the ring when implanted therein. Stated another way, the implanted tricuspid ring orients about a central flow axis aligned along an average direction of blood flow through the tricuspid annulus.
  • the rings of the present invention are 3-dimensional, portions thereof are planar and lie perpendicular to the flow axis.
  • FIGS. 7A-7C illustrate, in plan and septal and anterior elevational views, a tricuspid ring 50 of the present invention having a ring body 52 generally arranged about an axis 54 and being discontinuous so as to define two free ends 56 a , 56 b .
  • the axis 54 in FIG. 7A lies at the centroid of the ring or along of the axis of blood flow through the ring 50 when implanted, and it will be understood that the relative directions up and down are as viewed in FIG. 7B .
  • the ring 50 is designed to be implanted in a tricuspid annulus such that blood will flow in the downward direction.
  • the ring body 52 is substantially asymmetric and ovoid with the first free end 56 a located adjacent the antero-septal commissure (see FIG. 3 ).
  • the ring body 52 extends in a clockwise direction, as seen looking at the inflow side in FIG.
  • the precise relative dimensions of the segments may vary, but they are generally as indicated in the view of FIG. 7A . That is, the second segment 60 b is the largest, followed by the first segment 60 a , and then the smaller third segment 60 c and fourth segment 60 d . It should be further noted that the term “asymmetric” means that there are no planes of symmetry through the ring body 52 looking from the inflow side, and “ovoid” means generally shaped like an egg with a long axis and a short axis, and one long end larger than the other.
  • FIG. 8 shows the tricuspid ring 50 in plan view after having been implanted or otherwise affixed to a tricuspid valve.
  • the combined first and second segments 60 a and 60 b extend approximately around the tricuspid annulus between the two commissures 28 that bookend the septal leaflet 24 a .
  • a pair of commissure markers 62 a , 62 b on the exterior of the ring body 52 facilitate implantation by registering the ring 50 with respect to the commissures 28 .
  • the markers 62 a , 62 b are typically radially-oriented colored thread fastened to a fabric covering on the ring.
  • a majority of the ring body 52 is planar except for the free ends 56 a , 56 b which are upturned and the first segment 60 a and a part of fourth segment 60 d that are bowed upward. (To repeat, the “up” direction is merely for purpose of clarity herein and is synonymous with the inflow direction).
  • sizes 26 mm through 36 mm in 2 mm increments are available having outside diameters (OD) between 31.2-41.2 mm, and inside diameters (ID) between 24.3-34.3 mm. Again, these diameters are taken along the “diametric” line spanning the greatest length across the ring, as seen in FIG. 5A . It should be mentioned that the present invention is not limited to the aforementioned range of sizes, and larger rings of 38 or 40 mm OD are also possible, for example.
  • a gap G′ between the two free ends 56 a , 56 b is substantially larger than in certain rings of the prior art to reduce the risk of suturing into the AV node or bundle of His, and to accommodate variations in anatomy and location of the bundle of His.
  • the gap G′ is preferably between about 40%-50% of the labeled size, preferably between about 43-45%.
  • the gap G′ is about 40% of the size of the long axis of the ring, which is typically the labeled size in millimeters.
  • the gap G′ is desirably between about 10-18 mm, depending on the labeled size.
  • the gap G′ is preferably about 13.6 mm for a size 34 ring (about 40% of the labeled size).
  • the gap G′ is not too large to reduce the effective support for the septal leaflet 24 a .
  • the fourth segment 60 d of the ring 50 of the present invention extends at least half of the way around the septal leaflet 24 a.
  • the gap G′ is larger than the gap G in the rigid C-shaped Carpentier-Edwards Classic® Tricuspid Annuloplasty Ring, seen in FIGS. 5A and 5B .
  • the gap G for the various sizes of Classic® Rings ranges between about 5-8 mm, or between about 19%-22% of the labeled size.
  • the gap G′ of the ring of the present invention is larger than the gap in the flexible C-shaped SoveringTM tricuspid ring from Sorin Biomedica Cardio S.p.A.
  • the gap for the various sizes of the SoveringTM ranges between about 18-24 mm, or between about 60%-70% of the labeled size.
  • the gap G′ of the ring of the present invention is preferably greater than 8 mm and less than 18 mm, or is between about 23%-59% of the labeled size (typically equal to the dimension in millimeters of the long axis of the ring).
  • the free ends 56 a , 56 b of the exemplary ring 50 are upturned in the inflow direction so as to help reduce abrasion on the adjacent leaflets (septal, or both septal and antero-superior).
  • Prior rings that are not completely flexible terminate in ends that are extensions of the ring periphery, that is, they do not deviate from the paths that the adjacent segments of the ring follow.
  • the present ring 50 desirably includes a core member that provides at least some rigidity and structural support for the annulus.
  • the upturned ends 56 a , 56 b present curved surfaces that the constantly moving leaflets might repeatedly contact, as opposed to point surfaces so that forcible abrasion of the moving leaflets in contact with the ends of the ring is avoided.
  • the exemplary ring 50 also includes an upward arcuate bow or bulge 64 in the first segment 60 a , and another upward bulge 65 in the fourth segment 60 d .
  • the “aortic” bulge 64 accommodates a similar contour of the tricuspid annulus due to the external presence of the aorta and desirably extends from near the first free end 56 a along first segment 60 a to a location that corresponds to the end of the aortic part of the anterior leaflet.
  • Prior tricuspid rings are substantially planar, and if at all rigid they necessarily deform the annulus to some extent at this location.
  • the aortic bulge 64 helps reduce stress upon implant and concurrently reduces the chance of dehiscence, or the attaching sutures pulling out of the annulus.
  • the axial height h b of the aortic bulge 64 above the nominal top surface of the ring body 52 is between about 3-9 mm, preferably about 6 mm.
  • the “septal” bulge 65 conforms to the slight bulging of the septal leaflet attachment in this area.
  • the axial height h s of the septal bulge 65 above the nominal top surface of the ring body 52 is between about 2 to 4 mm.
  • the tricuspid ring 50 of the present invention is seen partially cutaway and in sections to illustrate further exemplary features.
  • the ring body 52 preferably comprises an inner core 70 encompassed by an elastomeric interface 72 and an outer fabric covering 74 .
  • the inner core 70 extends substantially around the entire periphery of the ring body 52 and is a relatively rigid material such as stainless steel, titanium, Elgiloy (an alloy primarily including Ni, Co, and Cr), Nitinol, and even certain polymers.
  • the term “relatively rigid” refers to the ability of the core 70 to support the annulus without substantial deformation, and implies a minimum elastic strength that enables the ring to maintain its original shape after implant even though it may flex somewhat. Indeed, as will be apparent, the ring desirably possesses some flexibility around its periphery.
  • the core 70 would not be made of silicone, which easily deforms to the shape of the annulus and therefore will not necessarily maintain its original shape upon implant.
  • the elastomeric interface 72 may be silicone rubber molded around the core 70 , or a similar expedient.
  • the elastomeric interface 72 provides bulk to the ring for ease of handling and implant, and permits passage of sutures though not significantly adding to the anchoring function of the outer fabric covering 74 .
  • the fabric covering 74 may be any biocompatible material such as Dacron® (polyethylene terepthalate). As seen in FIGS. 10A-10C , the elastomeric interface 72 and fabric covering 74 project outwards along the outside of the ring 50 to provide a platform through which to pass sutures.
  • the ring 50 of the present invention may possess a varying flexibility around its periphery.
  • the ring 50 is desirably stiffer adjacent the first free end 56 a than adjacent the second free end 56 b , and preferably has a gradually changing degree of flexibility for at least a portion in between.
  • the first segment 60 a may be relatively stiff while the remainder of the ring body 52 gradually becomes more flexible through the second segment 60 b , third segment 60 c , and fourth segment 60 d .
  • the fourth segment 60 d is more flexible than the third segment 60 c.
  • the flexibility of the fourth segment 60 d accommodates the inward movement of the annulus in that sector from fluid dynamic closing forces on the valve, and therefore reduces the chance of dehiscence. More particularly, radial forces exerted on the ring in the vertical direction, or along the small axis, will act on the flexible fourth segment 60 d and proportionately bend it inward, as indicated in phantom. This reduction in the antero-septal ring dimension, in turn, will reduce tension on the native valve leaflets that pull inward from valve closing forces. Tests have been conducted to determine the amount of force and movement associated with the septal aspect of the tricuspid annulus in both systole and diastole.
  • the flexibility of the fourth segment 60 d is such that it deforms inward by about 10% of the antero-septal (small axis) ring dimension under maximum load, typically resulting from right ventricular pressures of up to 70 mm Hg.
  • left ventricular pressures of up to 120 mm Hg are handled by a more robust mitral annulus.
  • the tricuspid annulus is more fragile and implanted annuluplasty rings are somewhat more prone to dehiscence.
  • variable flexibility consists of one or more points of localized flexibility, or “hinge points,” that may supplement the aforementioned gradually changing stiffness or be incorporated into an otherwise constant stiffness ring.
  • hinge points points of localized flexibility
  • the locations of the contemplated hinges are best described with reference to FIGS. 7A and 7B .
  • a central hinge created by an area of the ring body 52 that is locally more flexible than adjacent sectors is desirably located mid-way along the second segment 60 b , as indicated by a hinge line 66 .
  • This hinge is located approximately at the center of the length of the ring body 52 , and permits the segments on either side to flex or twist with respect to one another.
  • two generally diametrically-opposed hinge points indicated by hinge lines 61 and 67 may be provided. These hinges are located at the upward bulges 64 , 65 in the ring body 52 , and provide “saddle” flexibility so that the ring flexes generally in a plane intersecting the bulges.
  • a ring according to the present invention may have one or more of these hinges.
  • the discrete hinges or points of flexibility may be incorporated into rings having constant or variable flexibility, as described above.
  • 3-dimensional rings are shown, the several embodiments of flexibility described herein may also be provided in a flat, planar tricuspid ring, and with or without the increase gap between the free ends.
  • the ring body includes a core 70 made of a plurality of concentric peripheral bands having an axial dimension which is larger adjacent the first free end 56 a than adjacent the second free end 56 b .
  • Sectional FIGS. 10A-10C illustrate this embodiment.
  • the core 70 in the first segment 60 a (and possibly in a portion of the second segment 60 b ) is as seen in FIG. 10A , with six (6) concentric bands of a material such as Elgiloy.
  • a section of the core 701 still comprises six concentric bands, but its axial height is reduced relative to the height of the core as seen in FIG. 10A .
  • 10C shows a section through the third segment 60 c wherein a further section of the core 70 ′′ is further reduced in height but also only comprises four (4) concentric bands, with two of the bands having terminated or tapered off somewhere between sections 10 B and 10 C.
  • this construction is entirely exemplary and the core 70 could also be made of a single integral member that gradually tapers down in size, among other alternatives.
  • U.S. Pat. No. 5,104,407 to Lam, et al. the disclosure of which is expressly incorporated herein by reference.
  • FIG. 10D shows the internal structure of the ring body 52 at the second end 56 b .
  • the core 70 is shown bending upward into close proximity with the extreme tip of the free end 56 b , though it is protected by the elastomeric interface 72 and the outer fabric covering 74 .
  • the core 70 has its greatest flexibility at this location, which is mid-way around the septal leaflet side of the tricuspid annulus.
  • the upward bend of the core 70 and ring body 52 desirably makes an angle ⁇ of between 45°-90°, preferably greater than 60°.
  • the axial height h e as indicated in FIG.

Abstract

A prosthetic tricuspid remodeling annuloplasty ring having two free ends that are upturned in the inflow direction to help avoid unnecessary leaflet abrasion. The free ends are desirably separated across a gap that is large enough to reduce the risk of passing sutures through the conductive system of the heart, yet not too large that support of the septal leaflet of the tricuspid annulus is degraded. The tricuspid ring may have four sequential segments looking from the inflow side and extending in a clockwise direction from a free end located adjacent the antero septal commissure after implant. The ring may define an inflow bulge in the first segment and/or an inflow bulge in the fourth segment that help the ring conform to the natural bulges created by the adjacent aorta, thereby reducing stress and the potential for ring dehiscence. Desirably, the ring has variable flexibility, either gradual and/or between or within different segments, so as to adapt or harmonize its 3-dimensional shape to each individual patient and, therefore, to significantly reduce the constraints on the annulus and adjacent structures, particularly the leaflets and the conduction tissue.

Description

    FIELD OF THE INVENTION
  • The present invention relates generally to medical devices and particularly to a tricuspid annuloplasty ring.
  • BACKGROUND OF THE INVENTION
  • In vertebrate animals, the heart is a hollow muscular organ having four pumping chambers: the left and right atria and the left and right ventricles, each provided with its own one-way valve. The natural heart valves are identified as the aortic, mitral (or bicuspid), tricuspid and pulmonary, and are each mounted in an annulus comprising dense fibrous rings attached either directly or indirectly to the atrial and ventricular muscle fibers. Each annulus defines a flow orifice.
  • Heart valve disease is a widespread condition in which one or more of the valves of the heart fails to function properly. Diseased heart valves may be categorized as either stenotic, wherein the valve does not open sufficiently to allow adequate forward flow of blood through the valve, and/or incompetent, wherein the valve does not close completely, causing excessive backward flow of blood through the valve when the valve is closed. Valve disease can be severely debilitating and even fatal if left untreated.
  • Various surgical techniques may be used to repair a diseased or damaged valve. In a valve replacement operation, the damaged leaflets are excised and the annulus sculpted to receive a replacement valve. Another less drastic method for treating defective valves is through repair or reconstruction, which is typically used on minimally calcified valves. The most widely used repair technique is remodeling annuloplasty first proposed by the same inventor in which the deformed valve annulus is reshaped by attaching a prosthetic annuloplasty repair segment or ring to the valve annulus. The annuloplasty ring is designed to support the functional changes that occur during the cardiac cycle: maintaining coaptation and valve integrity to prevent reverse flow while permitting good hemodynamics during forward flow.
  • FIELD OF THE INVENTION
  • The present invention relates generally to medical devices and particularly to a tricuspid annuloplasty ring.
  • BACKGROUND OF THE INVENTION
  • In vertebrate animals, the heart is a hollow muscular organ having four pumping chambers: the left and right atria and the left and right ventricles, each provided with its own one-way valve. The natural heart valves are identified as the aortic, mitral (or bicuspid), tricuspid and pulmonary, and are each mounted in an annulus comprising dense fibrous rings attached either directly or indirectly to the atrial and ventricular muscle fibers. Each annulus defines a flow orifice.
  • Heart valve disease is a widespread condition in which one or more of the valves of the heart fails to function properly. Diseased heart valves may be categorized as either stenotic, wherein the valve does not open sufficiently to allow adequate forward flow of blood through the valve, and/or incompetent, wherein the valve does not close completely, causing excessive backward flow of blood through the valve when the valve is closed. Valve disease can be severely debilitating and even fatal if left untreated.
  • Various surgical techniques may be used to repair a diseased or damaged valve. In a valve replacement operation, the damaged leaflets are excised and the annulus sculpted to receive a replacement valve. Another less drastic method for treating defective valves is through repair or reconstruction, which is typically used on minimally calcified valves. The most widely used repair technique is remodeling annuloplasty first proposed by the same inventor in which the deformed valve annulus is reshaped by attaching a prosthetic annuloplasty repair segment or ring to the valve annulus. The annuloplasty ring is designed to support the functional changes that occur during the cardiac cycle: maintaining coaptation and valve integrity to prevent reverse flow while permitting good hemodynamics during forward flow.
  • The annuloplasty ring typically comprises an inner substrate of a metal such as rods or bands of stainless steel or titanium, or a flexible material such as silicone rubber or Dacron cordage, covered with a biocompatible fabric or cloth to allow the ring to be sutured to the fibrous annulus tissue. Annuloplasty rings may be stiff or flexible, split or continuous, and may have a variety of shapes, including circular, U-shaped, C-shaped, or kidney-shaped. Examples are seen in U.S. Pat. Nos. 5,041,130, 5,104,407, 5,201,880, 5,258,021, 5,607,471 and, 6,187,040 B1. Whether totally flexible, rigid, or semi-rigid, annuloplasty rings have sometimes been associated with a certain degree of arrhythmia or a 10% to 15% incidence at 10 years of ring dehiscence and/or conduction tissue disturbance. The present invention is intended to reduce the complications.
  • For the purposes of anatomic orientation, please refer to FIG. 1, which is a schematic representation of the AV junctions within the heart and the body in the left anterior oblique projection. The body is viewed in the upright position and has 3 orthogonal axes: superior-inferior, posterior-anterior, and right-left. Traditional nomenclature for the AV junctions derives from a surgically distorted view, placing the valvular rings in a single horizontal plane with antero-posterior and right-left lateral coordinates. The descriptive terms used, however, are anatomically inaccurate. An accurate account of the coordinates of the valvular orifices is provided by the simple expedient of relating appropriately the view obtained in left anterior oblique projection to the supero-inferior and antero-posterior coordinates of the body.
  • FIG. 2 is a cutaway view of the heart from the front, or anterior, perspective, with most of the primary structures marked. As is well known, the pathway of blood in the heart is from the right atrium to the right ventricle through the tricuspid valve, to and from the lungs, and from the left atrium to the left ventricle through the mitral valve. The present application has particular relevance to the repair of the tricuspid valve, which regulates blood flow between the right atrium and right ventricle, although certain aspects may apply to repair of other of the heart valves. The tricuspid and mitral valves together define the atrioventricular (AV) junctions.
  • As seen in FIG. 2, four structures embedded in the wall of the heart conduct impulses through the cardiac muscle to cause first the atria then the ventricles to contract. These structures are the sinoatrial node (SA node), the atrioventricular node (AV node), the bundle of His, and the Purkinje fibers. On the rear wall of the right atrium is a barely visible knot of tissue known as the sinoatrial, or SA node. This tiny area is the control of the heart's pacemaker mechanism. Impulse conduction normally starts in the SA node. It generates a brief electrical impulse of low intensity approximately 72 times every minute in a resting adult. From this point the impulse spreads out over the sheets of tissue that make up the two atria, exciting the muscle fibers as it does so. This causes contraction of the two atria and thereby thrusts the blood into the empty ventricles. The impulse quickly reaches another small specialized knot of tissue known as the atrioventricular, or AV node, located between the atria and the ventricles. This node delays the impulse for about 0.07 seconds, which is exactly enough time to allow the atria to complete their contractions. When the impulses reach the AV node, they are relayed by way of the several bundles of His and Purkinje fibers to the ventricles, causing them to contract. As those of skill in the art are aware, the integrity and proper functioning of the conductive system of the heart is critical for good health.
  • FIG. 3 is a schematic view of the tricuspid valve orifice seen from its inflow side (from the right atrium), with the peripheral landmarks labeled as: antero septal commissure, anterior leaflet, posterior commissure, posterior leaflet, postero septal commissure, and septal leaflet. Contrary to traditional orientation nomenclature, the tricuspid valve is nearly vertical, as reflected by these sector markings. From the same viewpoint, the tricuspid valve 20 is shown surgically exposed in FIG. 4 with an annulus 22 and three leaflets 24 a, 24 b, 24 c extending inward into the flow orifice. Chordae tendineae 26 connect the leaflets to papillary muscles located in the RV to control the movement of the leaflets. The tricuspid annulus 22 is an ovoid-shaped fibrous ring at the base of the valve that is less prominent than the mitral annulus, but larger in circumference.
  • Reflecting their true anatomic location, the three leaflets in FIG. 4 are identified as septal 24 a, anterior 24 b, and posterior (or “mural”) 24 c. The leaflets join together over three prominent zones of apposition, and the peripheral intersections of these zones are usually described as commissures 28. The leaflets 24 are tethered at the commissures 28 by the fan-shaped chordae tendineae 26 arising from prominent papillary muscles originating in the right ventricle. The septal leaflet 24 a is the site of attachment to the fibrous trigone, the fibrous “skeletal” structure within the heart. The anterior leaflet 24 b, largest of the 3 leaflets, often has notches. The posterior leaflet 24 c, smallest of the 3 leaflets, usually is scalloped.
  • The ostium 30 of the right coronary sinus opens into the right atrium, and the tendon of Todaro 32 extends adjacent thereto. The AV node 34 and the beginning of the bundle of His 36 are located in the supero-septal region of the tricuspid valve circumference. The AV node 34 is situated directly on the right atrial side of the central fibrous body in the muscular portion of the AV septum, just superior and anterior to the ostium 30 of the coronary sinus 30. Measuring approximately 1.0 mm×3.0 mm×6.0 mm, the node is flat and oval. The AV node 34 is located at the apex of the triangle of Koch 38, which is formed by the tricuspid annulus 22, the ostium 30 of the coronary sinus, and the tendon of Todaro 32. The AV node 34 continues on to the bundle of His 36, typically via a course inferior to the commissure 28 between the septal 24 a and anterior 24 b leaflets of the tricuspid valve; however, the precise course of the bundle of His 36 in the vicinity of the tricuspid valve may vary. Moreover, the location of the bundle of His 36 may not be readily apparent from a resected view of the right atrium because it lies beneath the annulus tissue.
  • The triangle of Koch 30 and tendon of Todaro 32 provide anatomic landmarks during tricuspid valve repair procedures. A major factor to consider during surgery is the proximity of the conduction system (AV node 34 and bundle of His 36) to the septal leaflet 24 a. Of course, surgeons must avoid placing sutures too close to or within the AV node 34. C-shaped rings are good choices for tricuspid valve repairs because they allow surgeons to position the break in the ring adjacent the AV node 34, thus avoiding the need for suturing at that location.
  • A rigid C-shaped ring of the prior art is the Carpentier-Edwards Classic® Tricuspid Annuloplasty Ring sold by Edwards Lifesciences Corporation of Irvine, Calif., which is seen in FIGS. 5A and 5B. Although not shown, the planar ring 40 has an inner titanium core (not shown) covered by a layer of silicone and fabric. Rings for sizes 26 mm through 36 mm in 2 mm increments have outside diameters (OD) between 31.2-41.2 mm, and inside diameters (ID) between 24.3-34.3 mm. These diameters are taken along the “diametric” line spanning the greatest length across the ring because that is the conventional sizing parameter. A gap G between free ends 42 a, 42 b in each provides the discontinuity to avoid attachment over the AV node 34. The gap G for the various sizes ranges between about 5-8 mm, or between about 19%-22% of the labeled size. As seen in the implanted view of FIG. 6, the gap G is sized just larger than the AV node 34. Despite this clearance, some surgeons are uncomfortable passing sutures so close to the conductive AV node 34, particularly considering the additional concern of the bundle of His 36.
  • A flexible C-shaped tricuspid ring is sold under the name Sovering™ by Sorin Biomedica Cardio S.p.A. of Via Crescentino, Italy. The Sovering™ is made with a radiopaque silicone core covered with a knitted polyester (PET) fabric so as to be totally flexible. Rings for sizes 28 mm through 36 mm in 2 mm increments have outside diameters (OD) between 33.8-41.8 mm, and inside diameters (ID) between 27.8-35.8 mm. As with other tricuspid rings, a gap between the free ends provides a discontinuity to avoid attachment over the AV node. The gap for the various sizes ranges of the Sovering™ ranges between about 18-24 mm, or between about 60%-70% of the labeled size. Although this gap helps avoid passing sutures close to the conductive AV node 34 and bundle of His 36, the ring is designed to be attached at the commissures on either side of the septal leaflet and thus no support is provided on the septal side.
  • Despite numerous designs presently available or proposed in the past, there is a need for a prosthetic tricuspid ring that better harmonizes with the anatomical and physiologic features of the tricuspid annulus, and in particular for a prosthetic tricuspid ring that better fits the contours of the tricuspid annulus and presents selective flexibility to reduce the stress in the attachment sutures, while at the same time reduces the risk of inadvertently passing a suture through the critical physiologic structures within the heart that conduct impulses.
  • SUMMARY OF THE INVENTION
  • The present invention provides a tricuspid annuloplasty ring including a ring body generally arranged in a plane and about an axis along an inflow-outflow direction, the ring body being discontinuous so as to define a first free end and a second free end separated across a gap, the two free ends being bent out of the plane in an inflow direction. Preferably, the two free ends are flexible and can be bent to have an axial height of between about 1-4 mm out of the plane.
  • Preferably, the ring body defines a generally asymmetric ovoid shape and extends in a clockwise direction from a first free end located adjacent the antero-septal commissure when implanted, as seen looking at the inflow side thereof, around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point. In one embodiment the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus. In a further embodiment, the ring body has an arcuate bulge out of the plane toward the inflow side at the fourth segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus. Still further, the ring body desirably has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end, or comprises at least one hinge point that is locally more flexible than adjacent segments. In one preferred construction, the ring body comprises a plurality of concentric peripheral bands having an axial dimension which is larger adjacent the first free end than adjacent the second free end. In a preferred embodiment, the ring has a long dimension in millimeters, and the free ends are separated by a distance of between about 40%-50% of the long dimension.
  • In accordance with another aspect of the invention, a prosthetic tricuspid annuloplasty ring having a long dimension in millimeters, comprises an asymmetric generally ovoid ring body. The ring body is generally arranged in a plane and about an axis along an inflow-outflow direction and is discontinuous so as to define two free ends. The ring body has a length and shape such that if a first free end is implanted adjacent an antero septal commissure of the tricuspid annulus, the ring body conforms to the tricuspid annulus and a second end is located adjacent a septal leaflet thereof, and the free ends are separated across a gap having a dimension of between about 40%-50% of the long dimension.
  • In the ring having a gap of between 40%-50% of the long dimension, the ring body extends in a clockwise direction from the first free end, as seen looking at the inflow side thereof around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point. In one embodiment the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus. In a further embodiment, the ring body has an arcuate bulge out of the plane toward the inflow side at the fourth segment. Still further, the ring body desirably has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end, or comprises at least one hinge point that is locally more flexible than adjacent segments.
  • In accordance with a still further aspect of the invention, a prosthetic tricuspid annuloplasty ring comprises an asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction with a first free end located adjacent an antero-septal commissure when implanted and a second free end located at a septal point. The ring body extends in a clockwise direction as seen looking at an inflow side from the first free end around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end. The ring body has an arcuate bulge out of the plane toward the inflow side at the first segment so as to accommodate an anatomical bulge of the aorta into the tricuspid annulus. The ring body may also have an arcuate bulge out of the plane toward the inflow side at the fourth segment. Desirably, the ring body has a varying flexibility and the fourth segment is relatively more flexible than the third segment. The first free end may also be stiffer than the second free end. Alternatively, the varying flexibility comprises at least one hinge point that is locally more flexible than adjacent segments.
  • In a further embodiment, and prosthetic tricuspid annuloplasty ring is provided that comprises an asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction with a first free end located adjacent an antero-septal commissure when implanted and a second free end located at a septal point. The ring body extends in a clockwise direction as seen looking at an inflow side from the first free end around a first segment, an second segment, a third segment, and a fourth segment that terminates in the second free end. The ring body has a variable flexibility comprising at least one hinge point that is locally more flexible than adjacent segments. Desirably, the hinge point is located at the approximate midpoint of the ring body. Alternatively, there are two hinge points located approximately diametrically opposite one another so that the ring flexes generally in a plane.
  • A further understanding of the nature and advantages of the invention will become apparent by reference to the remaining portions of the specification and drawings.
  • DESCRIPTION OF THE DRAWINGS
  • Features and advantages of the present invention will become appreciated as the same become better understood with reference to the specification, claims, and appended drawings wherein:
  • FIG. 1 is a schematic representation of the AV junctions within the heart and the body in the left anterior oblique projection;
  • FIG. 2 is a cutaway view of the heart from the front, or anterior, perspective;
  • FIG. 3 is a schematic plan view of the tricuspid annulus with typical orientation directions noted as seen from the inflow side;
  • FIG. 4 is a plan view of the native tricuspid valve and surrounding anatomy from the inflow side;
  • FIGS. 5A and 5B are plan and septal elevational views, respectively, of a planar tricuspid annuloplasty ring of the prior art;
  • FIG. 6 is a plan view of the native tricuspid valve and surrounding anatomy from the inflow side with the annuloplasty ring of FIGS. 5A-5B implanted;
  • FIGS. 7A-7C are plan and septal and anterior elevational views, respectively, of an exemplary tricuspid annuloplasty ring of the present invention illustrating its free ends bent toward the inflow side and an antero-superior bulge;
  • FIG. 8 is a plan view of the native tricuspid valve and surrounding anatomy from the inflow side with the annuloplasty ring of FIGS. 7A-7B implanted;
  • FIGS. 9A-9C are plan and septal and anterior elevational views, respectively, of the exemplary tricuspid annuloplasty ring of FIGS. 7A-7B with portions cutaway to show internal details; and
  • FIGS. 10A-10D are sectional views taken along respective section lines in FIG. 9A.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The present invention provides an improved tricuspid annuloplasty ring that better conforms to the native annulus and is shaped to protect certain features of the surrounding anatomy. The ring of the present invention is designed to support a majority of the tricuspid annulus without risking injury to the leaflet tissue and heart's conductive system, such as the AV node 34 and bundle of His 36 (see FIG. 4). Additionally, the present ring is contoured to better approximate the three-dimensional shape of the tricuspid annulus; specifically, the ring is substantially planar but includes a bulge in the inflow direction at the location of the bulge created by the adjacent aorta. The bulge helps reduce stress between the ring and surrounding tissue, and thus the potential for tearing or ring dehiscence.
  • Another feature that matches the present tricuspid ring with the physiological features of the annulus is a variable flexibility from a relatively stiff first segment to a relatively flexible fourth segment. This varying flexibility permits the ring to adapt (harmonize) its motion and 3-dimensional shape to that of the annulus, rather than impose its own motion and 3-D geometry thereto which tends to increase the risk of ring dehiscence. In particular, the motion of the tricuspid annulus during systole-diastole is believed to exert some torsional forces on the implanted ring, and the variable flexibility accommodates such torques. Moreover, localized points of flexibility or “hinges” around the ring as described herein may best conform and harmonize the physical properties of the ring to the annulus motion, while at the same time providing the needed corrective support.
  • It should also be understood that certain features of the present tricuspid ring might also be applicable and beneficial to rings for other of the heart's annuluses. For instance, the present ring includes upturned or bent free ends that help reduce abrasion on the adjacent leaflets. The same structure might be used in a discontinuous ring for the mitral valve annulus.
  • The term “axis” in reference to the illustrated ring, and other non-circular or non-planar rings, refers to a line generally perpendicular to the ring that passes through the area centroid of the ring when viewed in plan view. “Axial” or the direction of the “axis” can also be viewed as being parallel to the direction of blood flow within the valve orifice and thus within the ring when implanted therein. Stated another way, the implanted tricuspid ring orients about a central flow axis aligned along an average direction of blood flow through the tricuspid annulus. Although the rings of the present invention are 3-dimensional, portions thereof are planar and lie perpendicular to the flow axis.
  • FIGS. 7A-7C illustrate, in plan and septal and anterior elevational views, a tricuspid ring 50 of the present invention having a ring body 52 generally arranged about an axis 54 and being discontinuous so as to define two free ends 56 a, 56 b. The axis 54 in FIG. 7A lies at the centroid of the ring or along of the axis of blood flow through the ring 50 when implanted, and it will be understood that the relative directions up and down are as viewed in FIG. 7B. Using this convention, the ring 50 is designed to be implanted in a tricuspid annulus such that blood will flow in the downward direction.
  • As seen in FIGS. 7A-7C and also in FIGS. 9A-9C, the ring body 52 is substantially asymmetric and ovoid with the first free end 56 a located adjacent the antero-septal commissure (see FIG. 3). The ring body 52 extends in a clockwise direction, as seen looking at the inflow side in FIG. 7A, around a first segment 60 a corresponding to the aortic part of the anterior leaflet, a second segment 60 b corresponding to the remaining part of the anterior leaflet and ending at the postero septal commissure, a third segment 60 c from the postero septal commissure to a line 61 part way along the septal leaflet, and a fourth segment 60 d that terminates in the second free end 56 b at a septal point. The nomenclature for these segments is taken from the standard anatomical nomenclature around the tricuspid annulus as seen in FIG. 3.
  • The precise relative dimensions of the segments may vary, but they are generally as indicated in the view of FIG. 7A. That is, the second segment 60 b is the largest, followed by the first segment 60 a, and then the smaller third segment 60 c and fourth segment 60 d. It should be further noted that the term “asymmetric” means that there are no planes of symmetry through the ring body 52 looking from the inflow side, and “ovoid” means generally shaped like an egg with a long axis and a short axis, and one long end larger than the other.
  • FIG. 8 shows the tricuspid ring 50 in plan view after having been implanted or otherwise affixed to a tricuspid valve. To quantify relative to the native anatomy, the combined first and second segments 60 a and 60 b extend approximately around the tricuspid annulus between the two commissures 28 that bookend the septal leaflet 24 a. Accordingly, a pair of commissure markers 62 a, 62 b on the exterior of the ring body 52 facilitate implantation by registering the ring 50 with respect to the commissures 28. The markers 62 a, 62 b are typically radially-oriented colored thread fastened to a fabric covering on the ring.
  • A majority of the ring body 52 is planar except for the free ends 56 a, 56 b which are upturned and the first segment 60 a and a part of fourth segment 60 d that are bowed upward. (To repeat, the “up” direction is merely for purpose of clarity herein and is synonymous with the inflow direction). As with existing rings, sizes 26 mm through 36 mm in 2 mm increments are available having outside diameters (OD) between 31.2-41.2 mm, and inside diameters (ID) between 24.3-34.3 mm. Again, these diameters are taken along the “diametric” line spanning the greatest length across the ring, as seen in FIG. 5A. It should be mentioned that the present invention is not limited to the aforementioned range of sizes, and larger rings of 38 or 40 mm OD are also possible, for example.
  • A gap G′ between the two free ends 56 a, 56 b is substantially larger than in certain rings of the prior art to reduce the risk of suturing into the AV node or bundle of His, and to accommodate variations in anatomy and location of the bundle of His. In particular, the gap G′ is preferably between about 40%-50% of the labeled size, preferably between about 43-45%. In one configuration, the gap G′ is about 40% of the size of the long axis of the ring, which is typically the labeled size in millimeters. In absolute terms, the gap G′ is desirably between about 10-18 mm, depending on the labeled size. For instance, the gap G′ is preferably about 13.6 mm for a size 34 ring (about 40% of the labeled size). On the other hand, the gap G′ is not too large to reduce the effective support for the septal leaflet 24 a. Preferably, the fourth segment 60 d of the ring 50 of the present invention extends at least half of the way around the septal leaflet 24 a.
  • In a preferred embodiment, the gap G′ is larger than the gap G in the rigid C-shaped Carpentier-Edwards Classic® Tricuspid Annuloplasty Ring, seen in FIGS. 5A and 5B. The gap G for the various sizes of Classic® Rings ranges between about 5-8 mm, or between about 19%-22% of the labeled size. At the same time, the gap G′ of the ring of the present invention is larger than the gap in the flexible C-shaped Sovering™ tricuspid ring from Sorin Biomedica Cardio S.p.A. The gap for the various sizes of the Sovering™ ranges between about 18-24 mm, or between about 60%-70% of the labeled size. Therefore, the gap G′ of the ring of the present invention is preferably greater than 8 mm and less than 18 mm, or is between about 23%-59% of the labeled size (typically equal to the dimension in millimeters of the long axis of the ring).
  • The free ends 56 a, 56 b of the exemplary ring 50 are upturned in the inflow direction so as to help reduce abrasion on the adjacent leaflets (septal, or both septal and antero-superior). Prior rings that are not completely flexible terminate in ends that are extensions of the ring periphery, that is, they do not deviate from the paths that the adjacent segments of the ring follow. As will be explained below, the present ring 50 desirably includes a core member that provides at least some rigidity and structural support for the annulus. The upturned ends 56 a, 56 b present curved surfaces that the constantly moving leaflets might repeatedly contact, as opposed to point surfaces so that forcible abrasion of the moving leaflets in contact with the ends of the ring is avoided.
  • As seen in FIGS. 7B and 7C, the exemplary ring 50 also includes an upward arcuate bow or bulge 64 in the first segment 60 a, and another upward bulge 65 in the fourth segment 60 d. The “aortic” bulge 64 accommodates a similar contour of the tricuspid annulus due to the external presence of the aorta and desirably extends from near the first free end 56 a along first segment 60 a to a location that corresponds to the end of the aortic part of the anterior leaflet. Prior tricuspid rings are substantially planar, and if at all rigid they necessarily deform the annulus to some extent at this location. The aortic bulge 64 helps reduce stress upon implant and concurrently reduces the chance of dehiscence, or the attaching sutures pulling out of the annulus. The axial height hb of the aortic bulge 64 above the nominal top surface of the ring body 52, as indicated in FIG. 9C, is between about 3-9 mm, preferably about 6 mm. The “septal” bulge 65 conforms to the slight bulging of the septal leaflet attachment in this area. The axial height hs of the septal bulge 65 above the nominal top surface of the ring body 52, as indicated in FIG. 9B, is between about 2 to 4 mm. These two bulges 64, 65 provide a “saddle shape” to the ring body 52.
  • Now with particular reference to FIGS. 9A-9C and 10A-10D, the tricuspid ring 50 of the present invention is seen partially cutaway and in sections to illustrate further exemplary features. As seen best in the cutaway portion of FIG. 9B, the ring body 52 preferably comprises an inner core 70 encompassed by an elastomeric interface 72 and an outer fabric covering 74.
  • The inner core 70 extends substantially around the entire periphery of the ring body 52 and is a relatively rigid material such as stainless steel, titanium, Elgiloy (an alloy primarily including Ni, Co, and Cr), Nitinol, and even certain polymers. The term “relatively rigid” refers to the ability of the core 70 to support the annulus without substantial deformation, and implies a minimum elastic strength that enables the ring to maintain its original shape after implant even though it may flex somewhat. Indeed, as will be apparent, the ring desirably possesses some flexibility around its periphery. To further elaborate, the core 70 would not be made of silicone, which easily deforms to the shape of the annulus and therefore will not necessarily maintain its original shape upon implant.
  • The elastomeric interface 72 may be silicone rubber molded around the core 70, or a similar expedient. The elastomeric interface 72 provides bulk to the ring for ease of handling and implant, and permits passage of sutures though not significantly adding to the anchoring function of the outer fabric covering 74. The fabric covering 74 may be any biocompatible material such as Dacron® (polyethylene terepthalate). As seen in FIGS. 10A-10C, the elastomeric interface 72 and fabric covering 74 project outwards along the outside of the ring 50 to provide a platform through which to pass sutures.
  • As mentioned above, the ring 50 of the present invention may possess a varying flexibility around its periphery. In general, the ring 50 is desirably stiffer adjacent the first free end 56 a than adjacent the second free end 56 b, and preferably has a gradually changing degree of flexibility for at least a portion in between. For instance, the first segment 60 a may be relatively stiff while the remainder of the ring body 52 gradually becomes more flexible through the second segment 60 b, third segment 60 c, and fourth segment 60 d. In a preferred embodiment, the fourth segment 60 d is more flexible than the third segment 60 c.
  • With reference to FIG. 7A, the reader will appreciate that the flexibility of the fourth segment 60 d accommodates the inward movement of the annulus in that sector from fluid dynamic closing forces on the valve, and therefore reduces the chance of dehiscence. More particularly, radial forces exerted on the ring in the vertical direction, or along the small axis, will act on the flexible fourth segment 60 d and proportionately bend it inward, as indicated in phantom. This reduction in the antero-septal ring dimension, in turn, will reduce tension on the native valve leaflets that pull inward from valve closing forces. Tests have been conducted to determine the amount of force and movement associated with the septal aspect of the tricuspid annulus in both systole and diastole. Consequently, a preferred flexibility for the fourth segment 60 d has been determined and quantified in terms of the amount of desirable deformation under a given load. In one embodiment, the flexibility of the fourth segment 60 d is such that it deforms inward by about 10% of the antero-septal (small axis) ring dimension under maximum load, typically resulting from right ventricular pressures of up to 70 mm Hg. In contrast, left ventricular pressures of up to 120 mm Hg are handled by a more robust mitral annulus. The tricuspid annulus is more fragile and implanted annuluplasty rings are somewhat more prone to dehiscence.
  • Another potential configuration of variable flexibility consists of one or more points of localized flexibility, or “hinge points,” that may supplement the aforementioned gradually changing stiffness or be incorporated into an otherwise constant stiffness ring. The locations of the contemplated hinges are best described with reference to FIGS. 7A and 7B.
  • A central hinge created by an area of the ring body 52 that is locally more flexible than adjacent sectors is desirably located mid-way along the second segment 60 b, as indicated by a hinge line 66. This hinge is located approximately at the center of the length of the ring body 52, and permits the segments on either side to flex or twist with respect to one another. Alternatively, two generally diametrically-opposed hinge points indicated by hinge lines 61 and 67 may be provided. These hinges are located at the upward bulges 64, 65 in the ring body 52, and provide “saddle” flexibility so that the ring flexes generally in a plane intersecting the bulges. A ring according to the present invention may have one or more of these hinges. Also, as mentioned above, the discrete hinges or points of flexibility may be incorporated into rings having constant or variable flexibility, as described above. Finally, though 3-dimensional rings are shown, the several embodiments of flexibility described herein may also be provided in a flat, planar tricuspid ring, and with or without the increase gap between the free ends.
  • In one exemplary construction, the ring body includes a core 70 made of a plurality of concentric peripheral bands having an axial dimension which is larger adjacent the first free end 56 a than adjacent the second free end 56 b. Sectional FIGS. 10A-10C illustrate this embodiment. The core 70 in the first segment 60 a (and possibly in a portion of the second segment 60 b) is as seen in FIG. 10A, with six (6) concentric bands of a material such as Elgiloy. In the section of FIG. 10B, which is taken through the second segment 60 b, a section of the core 701 still comprises six concentric bands, but its axial height is reduced relative to the height of the core as seen in FIG. 10A. Finally, FIG. 10C shows a section through the third segment 60 c wherein a further section of the core 70″ is further reduced in height but also only comprises four (4) concentric bands, with two of the bands having terminated or tapered off somewhere between sections 10B and 10C. Of course, this construction is entirely exemplary and the core 70 could also be made of a single integral member that gradually tapers down in size, among other alternatives. Several other alternatives are disclosed in U.S. Pat. No. 5,104,407 to Lam, et al., the disclosure of which is expressly incorporated herein by reference.
  • FIG. 10D shows the internal structure of the ring body 52 at the second end 56 b. The core 70 is shown bending upward into close proximity with the extreme tip of the free end 56 b, though it is protected by the elastomeric interface 72 and the outer fabric covering 74. Desirably, the core 70 has its greatest flexibility at this location, which is mid-way around the septal leaflet side of the tricuspid annulus. The upward bend of the core 70 and ring body 52 desirably makes an angle θ of between 45°-90°, preferably greater than 60°. Furthermore, the axial height he, as indicated in FIG. 9C, of the free ends 56 a, 56 b above the nominal top surface of the ring body 52 is between about 1-4 mm, preferably about 2 mm, and preferably the two free ends project upward the same distance (although such a configuration is not an absolute requirement). Because of the flexibility of the ring body 52 at the second end 56 b, there is a reduction in the antero-septal dimension of the ring depending on the load applied by the annulus in the small axis (vertical) dimension.
  • While the foregoing is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Moreover, it will be obvious that certain other modifications may be practiced within the scope of the appended claims.

Claims (20)

1. A prosthetic tricuspid annuloplasty ring, comprising:
a ring body generally arranged in a plane and about an axis along an inflow-outflow direction, the ring body being discontinuous so as to define a first free end and a second free end separated across a gap, the two free ends being bent out of the plane in an inflow direction.
2. The prosthetic tricuspid annuloplasty ring of claim 1, wherein the ring body defines a generally asymmetric ovoid shape and extends in a clockwise direction from a first free end located adjacent the antero-septal commissure when implanted, as seen looking at the inflow side thereof, around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point, and wherein the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus.
3. The prosthetic tricuspid annuloplasty ring of claim 1, wherein the ring body defines a generally asymmetric ovoid shape and extends in a clockwise direction from a first free end located adjacent the antero-septal commissure when implanted, as seen looking at the inflow side thereof, around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point, and wherein the ring body has an arcuate bulge out of the plane toward the inflow side at the fourth segment.
4. The prosthetic tricuspid annuloplasty ring of claim 1, wherein the ring body defines a generally asymmetric ovoid shape and extends in a clockwise direction from a first free end located adjacent the antero-septal commissure when implanted, as seen looking at the inflow side thereof, around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point, and wherein the ring body has a varying flexibility and the fourth segment is relatively more flexible than the third segment.
5. The prosthetic tricuspid annuloplasty ring of claim 1, wherein the ring body has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end.
6. The prosthetic tricuspid annuloplasty ring of claim 1, wherein the ring body has a varying flexibility comprising at least one hinge point that is locally more flexible than adjacent segments.
7. The prosthetic tricuspid annuloplasty ring of claim 1, wherein the ring has a long dimension in millimeters, and the free ends are separated by a distance of between about 40%-50% of the long dimension.
8. The prosthetic tricuspid annuloplasty ring of claim 1, wherein the two free ends are each bent to have an axial height of between about 1-4 mm out of the plane.
9. A prosthetic tricuspid annuloplasty ring having a long dimension in millimeters, comprising:
an asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction and being discontinuous so as to define two free ends, the ring body having a length and shape such that if a first free end is implanted adjacent an antero septal commissure of the tricuspid annulus the ring body conforms to the tricuspid annulus and a second end is located adjacent a septal leaflet of the tricuspid annulus, and the free ends are separated across a gap having a dimension of between about 40%-50% of the long dimension.
10. The prosthetic tricuspid annuloplasty ring of claim 9, wherein the ring body extends in a clockwise direction from the first free end, as seen looking at the inflow side thereof around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point, and wherein the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment to accommodate an anatomical bulge of the aorta into the tricuspid annulus.
11. The prosthetic tricuspid annuloplasty ring of claim 9, wherein the ring body extends in a clockwise direction from the first free end, as seen looking at the inflow side thereof, around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end at a septal point, and wherein the ring body has an arcuate bulge out of the plane toward the inflow side at the fourth segment.
12. The prosthetic tricuspid annuloplasty ring of claim 9, wherein the ring body has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end.
13. The prosthetic tricuspid annuloplasty ring of claim 9, wherein the ring body has a varying flexibility comprising at least one hinge point that is locally more flexible than adjacent segments.
14. A prosthetic tricuspid annuloplasty ring, comprising:
an asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction with a first free end located adjacent an antero-septal commissure when implanted and a second free end located at a septal point, wherein the ring body extends in a clockwise direction as seen looking at an inflow side from the first free end around a first segment a second segment, a third segment, and a fourth segment that terminates in the second free end, and wherein the ring body has an arcuate bulge out of the plane toward the inflow side at the first segment so as to accommodate an anatomical bulge of the aorta into the tricuspid annulus.
15. The prosthetic tricuspid annuloplasty ring of claim 14, wherein the ring body an arcuate bulge out of the plane toward the inflow side at the fourth segment.
16. The prosthetic tricuspid annuloplasty ring of claim 14, wherein the ring body has a varying flexibility and is stiffer adjacent the first free end than adjacent the second free end.
17. The prosthetic tricuspid annuloplasty ring of claim 16, wherein the ring body has a varying flexibility comprising at least one hinge point that is locally more flexible than adjacent segments.
18. A prosthetic tricuspid annuloplasty ring, comprising:
an asymmetric generally ovoid ring body generally arranged in a plane and about an axis along an inflow-outflow direction with a first free end located adjacent an antero-septal commissure when implanted and a second free end located at a septal point, wherein the ring body extends in a clockwise direction as seen looking at an inflow side from the first free end around a first segment, a second segment, a third segment, and a fourth segment that terminates in the second free end, and wherein the ring body has a variable flexibility comprising at least one hinge point that is locally more flexible than adjacent segments.
19. The prosthetic tricuspid annuloplasty ring of claim 18, wherein the hinge point is located at the approximate midpoint of the ring body.
20. The prosthetic tricuspid annuloplasty ring of claim 18, wherein there are two hinge points located approximately diametrically opposite one another so that the ring flexes generally in a plane.
US12/120,184 2008-05-13 2008-05-13 Physiologically harmonized tricuspid annuloplasty ring Abandoned US20090287303A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US12/120,184 US20090287303A1 (en) 2008-05-13 2008-05-13 Physiologically harmonized tricuspid annuloplasty ring
JP2011509457A JP5390598B2 (en) 2008-05-13 2008-05-15 Physiologically harmonious tricuspid annuloplasty ring
CN200880129174.0A CN102088930B (en) 2008-05-13 2008-05-15 Physiologically harmonized tricuspid annuloplasty ring
EP08755581.9A EP2306933B1 (en) 2008-05-13 2008-05-15 Physiologically harmonized tricuspid annuloplasty ring
CA2721143A CA2721143C (en) 2008-05-13 2008-05-15 Physiologically harmonized tricuspid annuloplasty ring
PCT/US2008/063758 WO2009139776A1 (en) 2008-05-13 2008-05-15 Physiologically harmonized tricuspid annuloplasty ring
US13/600,040 US9937041B2 (en) 2008-05-13 2012-08-30 Physiologically harmonized tricuspid annuloplasty ring
US15/941,499 US20180221150A1 (en) 2008-05-13 2018-03-30 Physiologically harmonized tricuspid annuloplasty ring
US17/459,211 US11903830B2 (en) 2008-05-13 2021-08-27 Physiologically harmonized repair of tricuspid valve

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/120,184 US20090287303A1 (en) 2008-05-13 2008-05-13 Physiologically harmonized tricuspid annuloplasty ring

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/600,040 Continuation US9937041B2 (en) 2008-05-13 2012-08-30 Physiologically harmonized tricuspid annuloplasty ring

Publications (1)

Publication Number Publication Date
US20090287303A1 true US20090287303A1 (en) 2009-11-19

Family

ID=39590154

Family Applications (4)

Application Number Title Priority Date Filing Date
US12/120,184 Abandoned US20090287303A1 (en) 2008-05-13 2008-05-13 Physiologically harmonized tricuspid annuloplasty ring
US13/600,040 Active 2030-11-05 US9937041B2 (en) 2008-05-13 2012-08-30 Physiologically harmonized tricuspid annuloplasty ring
US15/941,499 Abandoned US20180221150A1 (en) 2008-05-13 2018-03-30 Physiologically harmonized tricuspid annuloplasty ring
US17/459,211 Active 2028-11-12 US11903830B2 (en) 2008-05-13 2021-08-27 Physiologically harmonized repair of tricuspid valve

Family Applications After (3)

Application Number Title Priority Date Filing Date
US13/600,040 Active 2030-11-05 US9937041B2 (en) 2008-05-13 2012-08-30 Physiologically harmonized tricuspid annuloplasty ring
US15/941,499 Abandoned US20180221150A1 (en) 2008-05-13 2018-03-30 Physiologically harmonized tricuspid annuloplasty ring
US17/459,211 Active 2028-11-12 US11903830B2 (en) 2008-05-13 2021-08-27 Physiologically harmonized repair of tricuspid valve

Country Status (6)

Country Link
US (4) US20090287303A1 (en)
EP (1) EP2306933B1 (en)
JP (1) JP5390598B2 (en)
CN (1) CN102088930B (en)
CA (1) CA2721143C (en)
WO (1) WO2009139776A1 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080208331A1 (en) * 2001-08-28 2008-08-28 Edwards Lifesciences Corporation Annuloplasty ring with offset free ends
US20080275551A1 (en) * 2007-05-01 2008-11-06 Edwards Lifesciences Corporation Inwardly-bowed tricuspid annuloplasty ring
US20090192605A1 (en) * 2008-01-25 2009-07-30 Medtronic, Inc. Sizer Device Having a Plurality of Anterior-Posterior Ratios
US7879087B2 (en) * 2006-10-06 2011-02-01 Edwards Lifesciences Corporation Mitral and tricuspid annuloplasty rings
US7959673B2 (en) * 2007-02-09 2011-06-14 Edwards Lifesciences Corporation Degenerative valvular disease specific annuloplasty rings
WO2011097251A1 (en) * 2010-02-03 2011-08-11 Genesee Biomedical, Inc. Semi-flexible annuloplasty ring
US20110238169A1 (en) * 2010-03-23 2011-09-29 Boston Scientific Scimed, Inc. Annuloplasty device
US20120136435A1 (en) * 2010-11-30 2012-05-31 Edwards Lifesciences Corporation Reduced Dehiscence Annuloplasty Ring
WO2012152959A1 (en) * 2011-05-06 2012-11-15 Sarraj Asil Anas Kit for anuloplasty of the tricuspid valve
US8915960B2 (en) 2010-08-31 2014-12-23 Edwards Lifesciences Corporation Physiologic tricuspid annuloplasty ring
US9101472B2 (en) 2007-09-07 2015-08-11 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US9149359B2 (en) 2001-08-28 2015-10-06 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring
US9326858B2 (en) 2010-08-24 2016-05-03 Edwards Lifesciences Corporation Flexible annuloplasty ring
WO2016201084A1 (en) * 2015-06-09 2016-12-15 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US9687346B2 (en) 2013-03-14 2017-06-27 Edwards Lifesciences Corporation Multi-stranded heat set annuloplasty rings
US9937041B2 (en) 2008-05-13 2018-04-10 Edwards Lifesciences Corporation Physiologically harmonized tricuspid annuloplasty ring
US10166101B2 (en) 2001-05-17 2019-01-01 Edwards Lifesciences Corporation Methods for repairing mitral valves
CN112437650A (en) * 2018-05-16 2021-03-02 李米德基金会 Semi-rigid annuloplasty ring and method of making same
US20210192836A1 (en) * 2018-08-30 2021-06-24 Olympus Corporation Recording device, image observation device, observation system, control method of observation system, and computer-readable recording medium
US20220202570A1 (en) * 2019-07-11 2022-06-30 Medtentia International Ltd Oy Annuloplasty Device
US11554015B2 (en) 2018-07-30 2023-01-17 Edwards Lifesciences Corporation Minimally-invasive low strain annuloplasty ring

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
EP2591755A1 (en) 2011-11-12 2013-05-15 Medtentia International Ltd Oy Device and method for improving fixation of a medical device
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
FR2998166B1 (en) * 2012-11-16 2016-02-26 Engin Oder ANNULAR PROSTHESIS FOR MUNTAL VALVE THERAPY BY ANNULO-PLASTIE
CN104000670B (en) * 2013-02-27 2016-12-28 金仕生物科技(常熟)有限公司 Adjustable artificial valve's ring
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
WO2015013861A1 (en) * 2013-07-29 2015-02-05 金仕生物科技(常熟)有限公司 Artificial heart valvuloplasty ring
RU2656530C2 (en) * 2013-10-25 2018-06-05 Кефалиос С.А.С. Adjustable annuloplasty ring and system
EP2904989A1 (en) * 2014-02-11 2015-08-12 Kephalios S.A.S. Adjustable annuloplasty device
DE202017007326U1 (en) 2016-01-29 2020-10-20 Neovasc Tiara Inc. Valve prosthesis to prevent flow obstruction
GB2548891B (en) 2016-03-31 2018-07-04 I Birdi Ltd A prosthetic device for mitral valve repair
CN107753153B (en) * 2016-08-15 2022-05-31 沃卡尔有限公司 Device and method for treating heart valve insufficiency
CN109996581B (en) 2016-11-21 2021-10-15 内奥瓦斯克迪亚拉公司 Methods and systems for rapid retrieval of transcatheter heart valve delivery systems
EP3395296B1 (en) 2017-04-28 2019-12-18 Medtentia International Ltd Oy Annuloplasty implant
CN111263622A (en) 2017-08-25 2020-06-09 内奥瓦斯克迪亚拉公司 Sequentially deployed transcatheter mitral valve prosthesis
CN108478310A (en) * 2018-06-08 2018-09-04 倪鸣 A kind of tricuspid valve forming ring of adjustable length and angle
EP3876870B1 (en) 2018-11-08 2023-12-20 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
CN109620474B (en) * 2018-11-24 2021-09-03 中国医学科学院阜外医院 Extensible tricuspid valve forming ring
JP7438236B2 (en) 2019-04-01 2024-02-26 ニオバスク ティアラ インコーポレイテッド Controllably deployable prosthetic valve
CA3136334A1 (en) 2019-04-10 2020-10-15 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
AU2020279750B2 (en) 2019-05-20 2023-07-13 Neovasc Tiara Inc. Introducer with hemostasis mechanism
AU2020295566B2 (en) 2019-06-20 2023-07-20 Neovasc Tiara Inc. Low profile prosthetic mitral valve
WO2023244861A1 (en) * 2022-06-17 2023-12-21 4C Medical Technologies, Inc. A prosthetic heart valve

Citations (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3656185A (en) * 1969-02-04 1972-04-18 Rhone Poulenc Sa Cardiac valvular support prosthesis
US4055861A (en) * 1975-04-11 1977-11-01 Rhone-Poulenc Industries Support for a natural human heart valve
US4164046A (en) * 1977-05-16 1979-08-14 Cooley Denton Valve prosthesis
US4217665A (en) * 1975-06-23 1980-08-19 Societe D'utilisation Scientifique Et Industrielle Du Froid - Usifroid Prosthesis for use in valvuloplasty
US4602911A (en) * 1982-08-19 1986-07-29 General Resorts S.A. Adjustable ringprosthesis
US5041130A (en) * 1989-07-31 1991-08-20 Baxter International Inc. Flexible annuloplasty ring and holder
US5061277A (en) * 1986-08-06 1991-10-29 Baxter International Inc. Flexible cardiac valvular support prosthesis
US5064431A (en) * 1991-01-16 1991-11-12 St. Jude Medical Incorporated Annuloplasty ring
US5104407A (en) * 1989-02-13 1992-04-14 Baxter International Inc. Selectively flexible annuloplasty ring
US5201880A (en) * 1992-01-27 1993-04-13 Pioneering Technologies, Inc. Mitral and tricuspid annuloplasty rings
US5258021A (en) * 1992-01-27 1993-11-02 Duran Carlos G Sigmoid valve annuloplasty ring
US5306296A (en) * 1992-08-21 1994-04-26 Medtronic, Inc. Annuloplasty and suture rings
US5450860A (en) * 1993-08-31 1995-09-19 W. L. Gore & Associates, Inc. Device for tissue repair and method for employing same
US5496336A (en) * 1989-07-31 1996-03-05 Baxter International Inc. Flexible suture guide and holder
US5593435A (en) * 1994-07-29 1997-01-14 Baxter International Inc. Distensible annuloplasty ring for surgical remodelling of an atrioventricular valve and nonsurgical method for post-implantation distension thereof to accommodate patient growth
US5607471A (en) * 1993-08-03 1997-03-04 Jacques Seguin Prosthetic ring for heart surgery
US5674279A (en) * 1992-01-27 1997-10-07 Medtronic, Inc. Annuloplasty and suture rings
US5776189A (en) * 1997-03-05 1998-07-07 Khalid; Naqeeb Cardiac valvular support prosthesis
US5824069A (en) * 1996-09-13 1998-10-20 Medtronic, Inc. Prosthetic heart valve with suturing member having non-uniform radial width
US5824066A (en) * 1995-12-01 1998-10-20 Medtronic, Inc. Annuloplasty prosthesis
US5972030A (en) * 1993-02-22 1999-10-26 Heartport, Inc. Less-invasive devices and methods for treatment of cardiac valves
US6019739A (en) * 1998-06-18 2000-02-01 Baxter International Inc. Minimally invasive valve annulus sizer
US6024918A (en) * 1998-03-13 2000-02-15 Medtronic, Inc. Method for attachment of biomolecules to surfaces of medical devices
US6102945A (en) * 1998-10-16 2000-08-15 Sulzer Carbomedics, Inc. Separable annuloplasty ring
US6143024A (en) * 1998-06-04 2000-11-07 Sulzer Carbomedics Inc. Annuloplasty ring having flexible anterior portion
US6159240A (en) * 1998-08-31 2000-12-12 Medtronic, Inc. Rigid annuloplasty device that becomes compliant after implantation
US6183512B1 (en) * 1999-04-16 2001-02-06 Edwards Lifesciences Corporation Flexible annuloplasty system
US6187040B1 (en) * 1999-05-03 2001-02-13 John T. M. Wright Mitral and tricuspid annuloplasty rings
US6217610B1 (en) * 1994-07-29 2001-04-17 Edwards Lifesciences Corporation Expandable annuloplasty ring
US6231602B1 (en) * 1999-04-16 2001-05-15 Edwards Lifesciences Corporation Aortic annuloplasty ring
US6250308B1 (en) * 1998-06-16 2001-06-26 Cardiac Concepts, Inc. Mitral valve annuloplasty ring and method of implanting
US6258122B1 (en) * 1995-11-01 2001-07-10 St. Jude Medical, Inc. Bioresorbable annuloplasty prosthesis
US6406493B1 (en) * 2000-06-02 2002-06-18 Hosheng Tu Expandable annuloplasty ring and methods of use
US6419696B1 (en) * 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
US20020133180A1 (en) * 2001-03-15 2002-09-19 Ryan Timothy R. Annuloplasty band and method
US20020129820A1 (en) * 2001-03-15 2002-09-19 Medtronic, Inc Annuloplasty band and method
US20020169504A1 (en) * 2001-05-14 2002-11-14 Alferness Clifton A. Mitral valve therapy device, system and method
US20020173844A1 (en) * 2001-05-17 2002-11-21 Ottavio Alfieri Annular prosthesis for mitral valve
US20030033009A1 (en) * 2000-05-22 2003-02-13 Shlomo Gabbay Cardiac prosthesis for helping improve operation of a heat valve
US20030040793A1 (en) * 2001-08-24 2003-02-27 Salvador Marquez Self-molding annuloplasty ring and method of use
US20030083742A1 (en) * 2000-02-02 2003-05-01 Paul A. Spence Heart valve repair apparatus and methods
US20030093148A1 (en) * 2001-11-13 2003-05-15 Bolling Steven F. Mitral valve annuloplasty ring for molding left ventricle geometry
US6602289B1 (en) * 1999-06-08 2003-08-05 S&A Rings, Llc Annuloplasty rings of particular use in surgery for the mitral valve
US6602288B1 (en) * 2000-10-05 2003-08-05 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery template, system and method of use
US6619291B2 (en) * 2001-04-24 2003-09-16 Edwin J. Hlavka Method and apparatus for catheter-based annuloplasty
US20030208264A1 (en) * 2001-08-28 2003-11-06 Mccarthy Patrick M. Three-dimensional annuloplasty ring and template
US20040006384A1 (en) * 2002-07-08 2004-01-08 Mccarthy Patrick Mitral valve annuluplasty ring having a posterior bow
US6709456B2 (en) * 2000-01-31 2004-03-23 Ev3 Santa Rosa, Inc. Percutaneous mitral annuloplasty with hemodynamic monitoring
US6719786B2 (en) * 2002-03-18 2004-04-13 Medtronic, Inc. Flexible annuloplasty prosthesis and holder
US6749639B2 (en) * 2001-08-27 2004-06-15 Mayo Foundation For Medical Education And Research Coated prosthetic implant
US20040249452A1 (en) * 2001-11-01 2004-12-09 Adams John M. Focused compression mitral valve device and method
US20040249453A1 (en) * 2002-08-29 2004-12-09 Cartledge Richard G. Methods for controlling the internal circumference of an anatomic orifice or lumen
US20050043791A1 (en) * 2001-08-28 2005-02-24 Mccarthy Patrick M. Three-dimensional annuloplasty ring and template
US20050131533A1 (en) * 2001-05-17 2005-06-16 Ottavio Alfieri Annuloplasty rings for repair of abnormal mitral valves
US6918917B1 (en) * 2000-10-10 2005-07-19 Medtronic, Inc. Minimally invasive annuloplasty procedure and apparatus
US20050192666A1 (en) * 2002-07-08 2005-09-01 Mccarthy Patrick Mitral valve annuloplasty ring having a posterior bow
US20050197696A1 (en) * 2004-02-23 2005-09-08 Gomez Duran Carlos M. Papilloplasty band and sizing device
US6942694B2 (en) * 2000-01-14 2005-09-13 Viacor, Inc. Tissue annuloplasty band and apparatus and method for fashioning, sizing and implanting the same
US20050246014A1 (en) * 2004-04-29 2005-11-03 Mccarthy Patrick M Annuloplasty ring for mitral valve prolapse
US20050256567A1 (en) * 2004-05-14 2005-11-17 St. Jude Medical, Inc. Heart valve annuloplasty prosthesis sewing cuffs and methods of making same
US20050256568A1 (en) * 2004-05-14 2005-11-17 St. Jude Medical, Inc. C-shaped heart valve prostheses
US20050256569A1 (en) * 2004-05-14 2005-11-17 St. Jude Medical, Inc. Flexible, non-planar annuloplasty rings
US6966924B2 (en) * 2002-08-16 2005-11-22 St. Jude Medical, Inc. Annuloplasty ring holder
US20050267572A1 (en) * 2004-05-14 2005-12-01 St. Jude Medical, Inc. Systems and methods for holding annuloplasty rings
US20050278022A1 (en) * 2004-06-14 2005-12-15 St. Jude Medical, Inc. Annuloplasty prostheses with improved anchoring structures, and related methods
US20050288777A1 (en) * 2004-06-29 2005-12-29 Rhee Richard S Thermal conductor for adjustable cardiac valve implant
US6986775B2 (en) * 2002-06-13 2006-01-17 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20060015178A1 (en) * 2004-07-15 2006-01-19 Shahram Moaddeb Implants and methods for reshaping heart valves
US20060015179A1 (en) * 2004-07-19 2006-01-19 Neil Bulman-Fleming Aortic annuloplasty ring
US20060020336A1 (en) * 2001-10-23 2006-01-26 Liddicoat John R Automated annular plication for mitral valve repair
US20060025858A1 (en) * 2004-07-27 2006-02-02 Alameddine Abdallah K Mitral valve ring for treatment of mitral valve regurgitation
US7037334B1 (en) * 2001-04-24 2006-05-02 Mitralign, Inc. Method and apparatus for catheter-based annuloplasty using local plications
US20060206203A1 (en) * 2005-03-10 2006-09-14 Jun Yang Valvular support prosthesis
US7118595B2 (en) * 2002-03-18 2006-10-10 Medtronic, Inc. Flexible annuloplasty prosthesis and holder
US7125421B2 (en) * 2001-08-31 2006-10-24 Mitral Interventions, Inc. Method and apparatus for valve repair
US7166127B2 (en) * 2003-12-23 2007-01-23 Mitralign, Inc. Tissue fastening systems and methods utilizing magnetic guidance
US20080086203A1 (en) * 2006-10-06 2008-04-10 Roberts Harold G Mitral and tricuspid annuloplasty rings

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489446A (en) 1982-07-14 1984-12-25 Reed Charles C Heart valve prosthesis
IT1218951B (en) 1988-01-12 1990-04-24 Mario Morea PROSTHETIC DEVICE FOR SURGICAL CORRECTION OF TRICUSPIDAL INSUFFICENCE
US4917698A (en) * 1988-12-22 1990-04-17 Baxter International Inc. Multi-segmented annuloplasty ring prosthesis
US7883539B2 (en) 1997-01-02 2011-02-08 Edwards Lifesciences Llc Heart wall tension reduction apparatus and method
EP0860151A1 (en) 1997-02-25 1998-08-26 Naqeeb Khalid Cardiac valvular support prosthesis
US6001127A (en) 1998-03-31 1999-12-14 St. Jude Medical, Inc. Annuloplasty ring holder
DE19910233A1 (en) 1999-03-09 2000-09-21 Jostra Medizintechnik Ag Anuloplasty prosthesis
FR2799364B1 (en) 1999-10-12 2001-11-23 Jacques Seguin MINIMALLY INVASIVE CANCELING DEVICE
WO2001047438A1 (en) 1999-12-23 2001-07-05 Edwards Lifesciences Corporation Enhanced visualization of medical implants
US6368348B1 (en) 2000-05-15 2002-04-09 Shlomo Gabbay Annuloplasty prosthesis for supporting an annulus of a heart valve
US6749630B2 (en) * 2001-08-28 2004-06-15 Edwards Lifesciences Corporation Tricuspid ring and template
US7087064B1 (en) 2002-10-15 2006-08-08 Advanced Cardiovascular Systems, Inc. Apparatuses and methods for heart valve repair
JP4594316B2 (en) 2003-10-03 2010-12-08 エドワーズ ライフサイエンシーズ コーポレイション Annuloplasty ring for repair of abnormal mitral valve
US7951196B2 (en) * 2004-04-29 2011-05-31 Edwards Lifesciences Corporation Annuloplasty ring for mitral valve prolapse
EP1951154B1 (en) 2005-10-26 2018-01-24 St. Jude Medical, Inc. Saddle-shaped mitral valve annuloplasty prostheses
EP3488822B1 (en) * 2007-01-26 2020-10-21 Medtronic, Inc. Annuloplasty device for tricuspid valve repair
US8529620B2 (en) * 2007-05-01 2013-09-10 Ottavio Alfieri Inwardly-bowed tricuspid annuloplasty ring
US20090287303A1 (en) 2008-05-13 2009-11-19 Edwards Lifesciences Corporation Physiologically harmonized tricuspid annuloplasty ring

Patent Citations (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3656185A (en) * 1969-02-04 1972-04-18 Rhone Poulenc Sa Cardiac valvular support prosthesis
US4055861A (en) * 1975-04-11 1977-11-01 Rhone-Poulenc Industries Support for a natural human heart valve
US4217665A (en) * 1975-06-23 1980-08-19 Societe D'utilisation Scientifique Et Industrielle Du Froid - Usifroid Prosthesis for use in valvuloplasty
US4164046A (en) * 1977-05-16 1979-08-14 Cooley Denton Valve prosthesis
US4602911A (en) * 1982-08-19 1986-07-29 General Resorts S.A. Adjustable ringprosthesis
US5061277A (en) * 1986-08-06 1991-10-29 Baxter International Inc. Flexible cardiac valvular support prosthesis
US5061277B1 (en) * 1986-08-06 2000-02-29 Baxter Travenol Lab Flexible cardiac valvular support prosthesis
US5104407A (en) * 1989-02-13 1992-04-14 Baxter International Inc. Selectively flexible annuloplasty ring
US5104407B1 (en) * 1989-02-13 1999-09-21 Baxter Int Selectively flexible annuloplasty ring
US5496336A (en) * 1989-07-31 1996-03-05 Baxter International Inc. Flexible suture guide and holder
US5041130A (en) * 1989-07-31 1991-08-20 Baxter International Inc. Flexible annuloplasty ring and holder
US6802860B2 (en) * 1989-07-31 2004-10-12 Edwards Lifesciences Corporation Annuloplasty ring delivery system
US5064431A (en) * 1991-01-16 1991-11-12 St. Jude Medical Incorporated Annuloplasty ring
US5674279A (en) * 1992-01-27 1997-10-07 Medtronic, Inc. Annuloplasty and suture rings
US5201880A (en) * 1992-01-27 1993-04-13 Pioneering Technologies, Inc. Mitral and tricuspid annuloplasty rings
US5258021A (en) * 1992-01-27 1993-11-02 Duran Carlos G Sigmoid valve annuloplasty ring
US5306296A (en) * 1992-08-21 1994-04-26 Medtronic, Inc. Annuloplasty and suture rings
US5972030A (en) * 1993-02-22 1999-10-26 Heartport, Inc. Less-invasive devices and methods for treatment of cardiac valves
US5607471A (en) * 1993-08-03 1997-03-04 Jacques Seguin Prosthetic ring for heart surgery
US5450860A (en) * 1993-08-31 1995-09-19 W. L. Gore & Associates, Inc. Device for tissue repair and method for employing same
US5888240A (en) * 1994-07-29 1999-03-30 Baxter International Inc. Distensible annuloplasty ring for surgical remodelling of an atrioventricular valve and nonsurgical method for post-implantation distension thereof to accomodate patient growth
US5593435A (en) * 1994-07-29 1997-01-14 Baxter International Inc. Distensible annuloplasty ring for surgical remodelling of an atrioventricular valve and nonsurgical method for post-implantation distension thereof to accommodate patient growth
US6217610B1 (en) * 1994-07-29 2001-04-17 Edwards Lifesciences Corporation Expandable annuloplasty ring
US6391054B2 (en) * 1994-07-29 2002-05-21 Edwards Lifesciences Corporation Expandable annuloplasty ring
US6258122B1 (en) * 1995-11-01 2001-07-10 St. Jude Medical, Inc. Bioresorbable annuloplasty prosthesis
US5824066A (en) * 1995-12-01 1998-10-20 Medtronic, Inc. Annuloplasty prosthesis
US5824069A (en) * 1996-09-13 1998-10-20 Medtronic, Inc. Prosthetic heart valve with suturing member having non-uniform radial width
US5776189A (en) * 1997-03-05 1998-07-07 Khalid; Naqeeb Cardiac valvular support prosthesis
US6024918A (en) * 1998-03-13 2000-02-15 Medtronic, Inc. Method for attachment of biomolecules to surfaces of medical devices
US6143024A (en) * 1998-06-04 2000-11-07 Sulzer Carbomedics Inc. Annuloplasty ring having flexible anterior portion
US6250308B1 (en) * 1998-06-16 2001-06-26 Cardiac Concepts, Inc. Mitral valve annuloplasty ring and method of implanting
US20010034551A1 (en) * 1998-06-16 2001-10-25 Cardiac Concepts, Inc. Mitral valve annuloplasty ring and method of implanting
US6019739A (en) * 1998-06-18 2000-02-01 Baxter International Inc. Minimally invasive valve annulus sizer
US6159240A (en) * 1998-08-31 2000-12-12 Medtronic, Inc. Rigid annuloplasty device that becomes compliant after implantation
US6102945A (en) * 1998-10-16 2000-08-15 Sulzer Carbomedics, Inc. Separable annuloplasty ring
US6231602B1 (en) * 1999-04-16 2001-05-15 Edwards Lifesciences Corporation Aortic annuloplasty ring
US6183512B1 (en) * 1999-04-16 2001-02-06 Edwards Lifesciences Corporation Flexible annuloplasty system
US6187040B1 (en) * 1999-05-03 2001-02-13 John T. M. Wright Mitral and tricuspid annuloplasty rings
US6602289B1 (en) * 1999-06-08 2003-08-05 S&A Rings, Llc Annuloplasty rings of particular use in surgery for the mitral valve
US6942694B2 (en) * 2000-01-14 2005-09-13 Viacor, Inc. Tissue annuloplasty band and apparatus and method for fashioning, sizing and implanting the same
US6709456B2 (en) * 2000-01-31 2004-03-23 Ev3 Santa Rosa, Inc. Percutaneous mitral annuloplasty with hemodynamic monitoring
US6797002B2 (en) * 2000-02-02 2004-09-28 Paul A. Spence Heart valve repair apparatus and methods
US20030083742A1 (en) * 2000-02-02 2003-05-01 Paul A. Spence Heart valve repair apparatus and methods
US7166126B2 (en) * 2000-02-02 2007-01-23 Paul A. Spence Heart valve repair apparatus and methods
US20030033009A1 (en) * 2000-05-22 2003-02-13 Shlomo Gabbay Cardiac prosthesis for helping improve operation of a heat valve
US6406493B1 (en) * 2000-06-02 2002-06-18 Hosheng Tu Expandable annuloplasty ring and methods of use
US6419696B1 (en) * 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
US6602288B1 (en) * 2000-10-05 2003-08-05 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery template, system and method of use
US6921407B2 (en) * 2000-10-10 2005-07-26 Medtronic, Inc. Minimally invasive annuloplasty procedure and apparatus
US6918917B1 (en) * 2000-10-10 2005-07-19 Medtronic, Inc. Minimally invasive annuloplasty procedure and apparatus
US20020133180A1 (en) * 2001-03-15 2002-09-19 Ryan Timothy R. Annuloplasty band and method
US6955689B2 (en) * 2001-03-15 2005-10-18 Medtronic, Inc. Annuloplasty band and method
US20020129820A1 (en) * 2001-03-15 2002-09-19 Medtronic, Inc Annuloplasty band and method
US20060025856A1 (en) * 2001-03-15 2006-02-02 Medtronic, Inc. Annuloplasty band and method
US6718985B2 (en) * 2001-04-24 2004-04-13 Edwin J. Hlavka Method and apparatus for catheter-based annuloplasty using local plications
US7037334B1 (en) * 2001-04-24 2006-05-02 Mitralign, Inc. Method and apparatus for catheter-based annuloplasty using local plications
US6619291B2 (en) * 2001-04-24 2003-09-16 Edwin J. Hlavka Method and apparatus for catheter-based annuloplasty
US6800090B2 (en) * 2001-05-14 2004-10-05 Cardiac Dimensions, Inc. Mitral valve therapy device, system and method
US20020169504A1 (en) * 2001-05-14 2002-11-14 Alferness Clifton A. Mitral valve therapy device, system and method
US6726717B2 (en) * 2001-05-17 2004-04-27 Edwards Lifesciences Corporation Annular prosthesis for mitral valve
US20020173844A1 (en) * 2001-05-17 2002-11-21 Ottavio Alfieri Annular prosthesis for mitral valve
US20050004666A1 (en) * 2001-05-17 2005-01-06 Ottavio Alfieri Annular prosthesis for mitral valve
US20050131533A1 (en) * 2001-05-17 2005-06-16 Ottavio Alfieri Annuloplasty rings for repair of abnormal mitral valves
US20030040793A1 (en) * 2001-08-24 2003-02-27 Salvador Marquez Self-molding annuloplasty ring and method of use
US6749639B2 (en) * 2001-08-27 2004-06-15 Mayo Foundation For Medical Education And Research Coated prosthetic implant
US20030208264A1 (en) * 2001-08-28 2003-11-06 Mccarthy Patrick M. Three-dimensional annuloplasty ring and template
US6908482B2 (en) * 2001-08-28 2005-06-21 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring and template
US20050182487A1 (en) * 2001-08-28 2005-08-18 Mccarthy Patrick M. Three-dimensional annuloplasty ring and template
US20050043791A1 (en) * 2001-08-28 2005-02-24 Mccarthy Patrick M. Three-dimensional annuloplasty ring and template
US7125421B2 (en) * 2001-08-31 2006-10-24 Mitral Interventions, Inc. Method and apparatus for valve repair
US20060020336A1 (en) * 2001-10-23 2006-01-26 Liddicoat John R Automated annular plication for mitral valve repair
US20040249452A1 (en) * 2001-11-01 2004-12-09 Adams John M. Focused compression mitral valve device and method
US7329280B2 (en) * 2001-11-13 2008-02-12 Edwards Lifesciences Corp. Methods of implanting a mitral valve annuloplasty ring to correct mitral regurgitation
US20030093148A1 (en) * 2001-11-13 2003-05-15 Bolling Steven F. Mitral valve annuloplasty ring for molding left ventricle geometry
US6805710B2 (en) * 2001-11-13 2004-10-19 Edwards Lifesciences Corporation Mitral valve annuloplasty ring for molding left ventricle geometry
US6719786B2 (en) * 2002-03-18 2004-04-13 Medtronic, Inc. Flexible annuloplasty prosthesis and holder
US7118595B2 (en) * 2002-03-18 2006-10-10 Medtronic, Inc. Flexible annuloplasty prosthesis and holder
US7066954B2 (en) * 2002-03-18 2006-06-27 Medtronic, Inc. Annuloplasty system
US6986775B2 (en) * 2002-06-13 2006-01-17 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US6858039B2 (en) * 2002-07-08 2005-02-22 Edwards Lifesciences Corporation Mitral valve annuloplasty ring having a posterior bow
US20050192666A1 (en) * 2002-07-08 2005-09-01 Mccarthy Patrick Mitral valve annuloplasty ring having a posterior bow
US20040006384A1 (en) * 2002-07-08 2004-01-08 Mccarthy Patrick Mitral valve annuluplasty ring having a posterior bow
US6966924B2 (en) * 2002-08-16 2005-11-22 St. Jude Medical, Inc. Annuloplasty ring holder
US20040249453A1 (en) * 2002-08-29 2004-12-09 Cartledge Richard G. Methods for controlling the internal circumference of an anatomic orifice or lumen
US7166127B2 (en) * 2003-12-23 2007-01-23 Mitralign, Inc. Tissue fastening systems and methods utilizing magnetic guidance
US20050197696A1 (en) * 2004-02-23 2005-09-08 Gomez Duran Carlos M. Papilloplasty band and sizing device
US20050246014A1 (en) * 2004-04-29 2005-11-03 Mccarthy Patrick M Annuloplasty ring for mitral valve prolapse
US7294148B2 (en) * 2004-04-29 2007-11-13 Edwards Lifesciences Corporation Annuloplasty ring for mitral valve prolapse
US20050267572A1 (en) * 2004-05-14 2005-12-01 St. Jude Medical, Inc. Systems and methods for holding annuloplasty rings
US20050256567A1 (en) * 2004-05-14 2005-11-17 St. Jude Medical, Inc. Heart valve annuloplasty prosthesis sewing cuffs and methods of making same
US20050256568A1 (en) * 2004-05-14 2005-11-17 St. Jude Medical, Inc. C-shaped heart valve prostheses
US20050256569A1 (en) * 2004-05-14 2005-11-17 St. Jude Medical, Inc. Flexible, non-planar annuloplasty rings
US20050278022A1 (en) * 2004-06-14 2005-12-15 St. Jude Medical, Inc. Annuloplasty prostheses with improved anchoring structures, and related methods
US20050288778A1 (en) * 2004-06-29 2005-12-29 Emanuel Shaoulian Selectively adjustable cardiac valve implants
US20050288776A1 (en) * 2004-06-29 2005-12-29 Emanuel Shaoulian Adjustable cardiac valve implant with coupling mechanism
US20050288777A1 (en) * 2004-06-29 2005-12-29 Rhee Richard S Thermal conductor for adjustable cardiac valve implant
US20060015178A1 (en) * 2004-07-15 2006-01-19 Shahram Moaddeb Implants and methods for reshaping heart valves
US20060015179A1 (en) * 2004-07-19 2006-01-19 Neil Bulman-Fleming Aortic annuloplasty ring
US20060025858A1 (en) * 2004-07-27 2006-02-02 Alameddine Abdallah K Mitral valve ring for treatment of mitral valve regurgitation
US20060206203A1 (en) * 2005-03-10 2006-09-14 Jun Yang Valvular support prosthesis
US20080086203A1 (en) * 2006-10-06 2008-04-10 Roberts Harold G Mitral and tricuspid annuloplasty rings

Cited By (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10166101B2 (en) 2001-05-17 2019-01-01 Edwards Lifesciences Corporation Methods for repairing mitral valves
US8114155B2 (en) * 2001-08-28 2012-02-14 Edwards Lifesciences Corporation Annuloplasty ring with offset free ends
US9414922B2 (en) 2001-08-28 2016-08-16 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring
US9149359B2 (en) 2001-08-28 2015-10-06 Edwards Lifesciences Corporation Three-dimensional annuloplasty ring
US10188518B2 (en) 2001-08-28 2019-01-29 Edwards Lifesciences Corporation Annuloplasty ring with variable cross-section
US20080208331A1 (en) * 2001-08-28 2008-08-28 Edwards Lifesciences Corporation Annuloplasty ring with offset free ends
US8382828B2 (en) * 2006-10-06 2013-02-26 Edwards Lifesciences Corporation Mitral annuloplasty rings
US20110093065A1 (en) * 2006-10-06 2011-04-21 Edwards Lifesciences Corporation Mitral and Tricuspid Annuloplasty Rings
US7879087B2 (en) * 2006-10-06 2011-02-01 Edwards Lifesciences Corporation Mitral and tricuspid annuloplasty rings
US8764821B2 (en) 2007-02-09 2014-07-01 Edwards Lifesciences Corporation Degenerative vavlular disease specific annuloplasty ring sets
US7959673B2 (en) * 2007-02-09 2011-06-14 Edwards Lifesciences Corporation Degenerative valvular disease specific annuloplasty rings
US20080275551A1 (en) * 2007-05-01 2008-11-06 Edwards Lifesciences Corporation Inwardly-bowed tricuspid annuloplasty ring
US8529620B2 (en) * 2007-05-01 2013-09-10 Ottavio Alfieri Inwardly-bowed tricuspid annuloplasty ring
US11576784B2 (en) 2007-09-07 2023-02-14 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US9101472B2 (en) 2007-09-07 2015-08-11 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US10842629B2 (en) 2007-09-07 2020-11-24 Edwards Lifesciences Corporation Active holder for annuloplasty ring delivery
US8795353B2 (en) 2008-01-25 2014-08-05 Medtronic, Inc. Holder devices for annuloplasty devices having a plurality of anterior-posterior ratios
US20090192606A1 (en) * 2008-01-25 2009-07-30 Medtronic, Inc. Holder Devices for Annuloplasty Devices Having a Plurality of Anterior-Posterior Ratios
US7993395B2 (en) 2008-01-25 2011-08-09 Medtronic, Inc. Set of annuloplasty devices with varying anterior-posterior ratios and related methods
US20120022643A1 (en) * 2008-01-25 2012-01-26 Hugo Vanermen Set of Annuloplasty Devices with Varying Anterior-Posterior Ratios and Related Methods
US20090192605A1 (en) * 2008-01-25 2009-07-30 Medtronic, Inc. Sizer Device Having a Plurality of Anterior-Posterior Ratios
US8961598B2 (en) * 2008-01-25 2015-02-24 Medtronic, Inc. Set of annuloplasty devices with varying anterior-posterior ratios and related methods
US11903830B2 (en) 2008-05-13 2024-02-20 Edwards Lifesciences Corporation Physiologically harmonized repair of tricuspid valve
US9937041B2 (en) 2008-05-13 2018-04-10 Edwards Lifesciences Corporation Physiologically harmonized tricuspid annuloplasty ring
WO2011097251A1 (en) * 2010-02-03 2011-08-11 Genesee Biomedical, Inc. Semi-flexible annuloplasty ring
CN102985031A (en) * 2010-02-03 2013-03-20 美敦力Gbi有限公司 Semi-flexible annuloplasty ring
US8556966B2 (en) * 2010-03-23 2013-10-15 Boston Scientific Scimed, Inc. Annuloplasty device
US20110238169A1 (en) * 2010-03-23 2011-09-29 Boston Scientific Scimed, Inc. Annuloplasty device
US10182912B2 (en) 2010-08-24 2019-01-22 Edwards Lifesciences Corporation Methods of delivering a flexible annuloplasty ring
US9326858B2 (en) 2010-08-24 2016-05-03 Edwards Lifesciences Corporation Flexible annuloplasty ring
US10940003B2 (en) 2010-08-24 2021-03-09 Edwards Lifesciences Corporation Methods of delivering a flexible annuloplasty ring
US8915960B2 (en) 2010-08-31 2014-12-23 Edwards Lifesciences Corporation Physiologic tricuspid annuloplasty ring
US10543089B2 (en) 2010-11-30 2020-01-28 Edwards Lifesciences Corporation Annuloplasty ring with reduced dehiscence
US20120136435A1 (en) * 2010-11-30 2012-05-31 Edwards Lifesciences Corporation Reduced Dehiscence Annuloplasty Ring
US11872132B2 (en) * 2010-11-30 2024-01-16 Edwards Lifesciences Corporation Methods of implanting an annuloplasty ring for reduced dehiscence
US9474607B2 (en) * 2010-11-30 2016-10-25 Edwards Lifesciences Corporation Methods of implanting an annuloplasty ring for reduced dehiscence
US20150127099A1 (en) * 2010-11-30 2015-05-07 Edwards Lifesciences Corporation Methods of implanting an annuloplasty ring for reduced dehiscence
US8932350B2 (en) * 2010-11-30 2015-01-13 Edwards Lifesciences Corporation Reduced dehiscence annuloplasty ring
WO2012074993A3 (en) * 2010-11-30 2012-08-16 Edwards Lifesciences Corporation Reduced dehiscence annuloplasty ring
CN103249376A (en) * 2010-11-30 2013-08-14 爱德华兹生命科学公司 Reduced dehiscence annuloplasty ring
ES2392416A1 (en) * 2011-05-06 2012-12-10 Anas SARRAJ ASIL Kit for anuloplasty of the tricuspid valve
WO2012152959A1 (en) * 2011-05-06 2012-11-15 Sarraj Asil Anas Kit for anuloplasty of the tricuspid valve
US10265171B2 (en) 2013-03-14 2019-04-23 Edwards Lifesciences Corporation Multi-stranded heat set annuloplasty rings
US11045319B2 (en) 2013-03-14 2021-06-29 Edwards Lifesciences Corporation Methods of forming heat set annuloplasty rings
US9687346B2 (en) 2013-03-14 2017-06-27 Edwards Lifesciences Corporation Multi-stranded heat set annuloplasty rings
WO2016201084A1 (en) * 2015-06-09 2016-12-15 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
CN111529132A (en) * 2015-06-09 2020-08-14 爱德华兹生命科学有限责任公司 Asymmetrical mitral annuloplasty band
US10314707B2 (en) * 2015-06-09 2019-06-11 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US11324593B2 (en) 2015-06-09 2022-05-10 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US11938027B2 (en) * 2015-06-09 2024-03-26 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US11471280B2 (en) * 2015-06-09 2022-10-18 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US20160361170A1 (en) * 2015-06-09 2016-12-15 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
US11918467B2 (en) 2018-05-16 2024-03-05 Fondazione Ri. Med Semi-rigid annuloplasty ring and method of manufacturing
CN112437650A (en) * 2018-05-16 2021-03-02 李米德基金会 Semi-rigid annuloplasty ring and method of making same
US11554015B2 (en) 2018-07-30 2023-01-17 Edwards Lifesciences Corporation Minimally-invasive low strain annuloplasty ring
US11653815B2 (en) * 2018-08-30 2023-05-23 Olympus Corporation Recording device, image observation device, observation system, control method of observation system, and computer-readable recording medium
US20210192836A1 (en) * 2018-08-30 2021-06-24 Olympus Corporation Recording device, image observation device, observation system, control method of observation system, and computer-readable recording medium
US11491008B2 (en) * 2019-07-11 2022-11-08 Medtentia International Ltd Oy Annuloplasty device
US20220202570A1 (en) * 2019-07-11 2022-06-30 Medtentia International Ltd Oy Annuloplasty Device

Also Published As

Publication number Publication date
CN102088930B (en) 2014-10-15
JP2011520505A (en) 2011-07-21
WO2009139776A1 (en) 2009-11-19
CA2721143A1 (en) 2009-11-19
EP2306933A1 (en) 2011-04-13
JP5390598B2 (en) 2014-01-15
US11903830B2 (en) 2024-02-20
US20180221150A1 (en) 2018-08-09
US9937041B2 (en) 2018-04-10
EP2306933B1 (en) 2014-06-04
CN102088930A (en) 2011-06-08
US20120330412A1 (en) 2012-12-27
CA2721143C (en) 2013-06-25
US20210401577A1 (en) 2021-12-30

Similar Documents

Publication Publication Date Title
US11903830B2 (en) Physiologically harmonized repair of tricuspid valve
US11872132B2 (en) Methods of implanting an annuloplasty ring for reduced dehiscence
EP2142144B1 (en) Inwardly-bowed tricuspid annuloplasty ring
US8449608B2 (en) Tricuspid ring
US11938027B2 (en) Asymmetric mitral annuloplasty band
US20110160849A1 (en) Bimodal tricuspid annuloplasty ring
WO2007089625A1 (en) Annuloplasty ring for mitral valve prolapse

Legal Events

Date Code Title Description
AS Assignment

Owner name: EDWARDS LIFESCIENCES CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CARPENTIER, ALAIN;REEL/FRAME:021414/0665

Effective date: 20080711

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION